Комплексное автоматизированное прогнозирование кардиоваскулярного риска в формировании групп первичной профилактики
Диссертация
Актуальность проблемы. Высокие показатели смертности в современной России обусловлены, в первую очередь, неинфекционными заболеваниями и травмами («Здравоохранение в России 2009» Росстат, 2009). Отмечено возрастание заболеваемости взрослого населения России ИБС в течение 1991;2006 гг. в 1,71 раза, ЦВЗ — 2,14 раза (Тишук Е.А., 2009). Число умерших молодых людей в возрасте 20−29 и 30−44 лет… Читать ещё >
Список литературы
- Алмазов, В.А. Эндотелиальная дисфункция у больных с дебютом ишемической болезни сердца в разном возрасте / В. А. Алмазов, O.A. Беркович, М. Ю. Ситникова и др. // Кардиология. 2001. — № 5. — С. 26−29.
- Ананьев, В. Н. Механизмы адаптации к холоду и реакция на холод системного кровообращения / Ананьев В. Н, Мирюк M. Н. // Вестник Тверского государственного университета. 2009. — № 16. — С. 24−28.
- Бахтияров, Р.З. Современные методы исследования функции эндотелия / Р. З. Бахтияров // Рос. кардиологии, журн. 2004. — № 2. — С. 76−79.
- Бойцов, С.А. Проблемы выявления лиц с высоким сердечно-сосудистым риском и возможные пути их решения (часть I) / С. А. Бойцов, Ю. А. Карпов,
- B.В. Кухарчук, А. Н. Рогоза, Т. В. Балахонова, С. Ж. Уразалина, Т. И. Коткина,
- C.К. Терновой, М. М. Салтыкова, И. В. Сергиенко // Атеросклероз и дислипидемии. 2010. — № 1. — С. 8−14.
- Галушкин, А.И. Теория нейронных сетей / А. И. Галушкин. М.: ИПРЖР, 2000.-416 с.
- Гельцер, Б.И. Комплексная оценка вазомоторной функции сосудистого эндотелия у больных с артериальной гипертензией / Б. И. Гельцер, C.B. Савченко, В. Н. Котельников, И. В. Плотникова // Кардиология. 2004. — № 4. — С. 24−28.
- Герасименко, Н.Ф. Женское сердце / Н. Ф. Герасименко, Р. Г. Оганов, В. Б. Мычка // Кардиоваскулярная терапия и профилактика. 2011. — Т. 10, № 1. — С. 5−7.
- Герасимова, Jl. И. Частота холод-ассоциированных симптомов у пациентов с терапевтической патологией / Л. И. Герасимова // Вестник РУДН. 2003. -Т. 24, № 5.-С. 61−65.
- Герасимова, Л. И. Усиленная холод-индуцированная вазоконстрикция как донозологический признак при адаптации к условиям севера / Л. И. Герасимова // Ученые записки Петрозаводского государственного университета. 2008. — № 96. — С. 69−71.
- Гланц, С. Медико-биологическая статистика : пер с англ. / С. Гланц. М.: Практика, 1998.-459 с.
- Горбань, А.Н. Нейрокомпьютер или аналоговый ренессанс / А. Н. Горбань // МИР ПК. 1994. — № 10. — С. 126−130.
- Государственный доклад о состоянии здоровья населения Российской Федерации в 2006 г. М., 2007. — 80 с.
- Гублер, Е.В. Применение непараметричеих критериев статичтики вмедико-биологических исследованиях / Е. В. Гублер, Генкин A.A. // Л: Медицина, 1973. -141 с.
- Демографический ежегодник России 2008. Статистический сборник: официальное изд. / ред. А. Е. Суринов. -М.: Росстат, 2010. 528 с.
- Де Фритас, Г. Р. Первичная профилактика инсульта / Г. Р. Де Фритас, Д. Богусславски // Журнал неврологии и психиатрии им. С. С. Корсакова. -2001. Приложение «Инсульт». — № 1. — С. 7−20.
- Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. IV пересмотр. Российские рекомендации ВНОК // Кардиоваскулярная терапия и профилактика. 2009. — Т. 8, № 6 (Прил. 3). — 136 с.
- Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. V пересмотр. Российские рекомендации РКО // Атеросклероз и дислипидемии. 2012. — № 4. — С. 5−52.
- Евдокимова, A.A. Оценка распространенности факторов риска в случайной городской выборке мужчин и женщин / A.A. Евдокимова, М. Н. Мамедов, С. А. Шальнова и др. // Профилактическая медицина. 2010. -№ 2. — С. 3−8.
- Затейщиков, Д.А. Функциональное состояние эндотелия у больных артериальнойгипертонией и ишемической болезнью сердца / Д. А. Затейщиков, J1.0. Минушкина, О. Ю. Кудряшова и др. // Кардиология. 2000. — № 6. — С. 14−17.
- Затейщикова, А.А. Эндотелиальная регуляция сосудистого тонуса: методы исследования и клиническое значение / А. А. Затейщикова, Д. А. Затейщиков // Кардиология. 1998. — № 9. — С. 68−80.
- Здравоохранение в России 2009. Статистический сборник / Россгат. М., 2009. — 365 с.
- Ибатов, А.Д. Влияние тревожных расстройств на течение ишемической болезни сердца / А. Д. Ибатов // Рус. мед. журн. 2007. — Т. 15, № 20. — С. 1443−1448.
- Кардиоваскулярная профилактика. Национальные рекомендации // Кардиоваскулярная терапия и профилактика. 2011. — Т. 10, № 6. — 64 с.
- Кательницкая, Л. И Особенности течения артериальной гипертензии в пожилом возрасте и пути ее коррекции / Л. И. Кательницкая, Л. А. Хаишева, С. А. Плескачев // Кардиоваскулярная терапия и профилактика. 2006. — № 6. — С. 17−22.
- Климов, А.Н. Гиперлипидемия как главный фактор в патогенезе атеросклероза. Превентивная кардиология / А. Н. Климов. М.: Медицина, 1977. — С. 307−315.
- Ковалев, И.А. Дисфункция эндотелия у лиц с отягощенной по атеросклерозу наследственностью / И. А. Ковалев, Г. И. Марцинкевич, Т. Е. Суслова, А. А. Соколов // Кардиология. 2004. — № 1. — С. 39−42.
- Кухарчук, В.В. Дислипидемии и сердечно-сосудистые заболевания // Consilium medicum. 2009. — Том 11, N5. — С. 61−64.
- Кухарчук, В.В. Вести с 78 конгресса Европейского общества атеросклероза (EAS) // Атеросклероз и дислипидемии. 2010. — № 1. — С. 45−49.
- Лакин, Г. Ф. Биометрия / Г. Ф. Лакин. М.: Высшая школа, 1990. — 351 с.
- Максимова, Т.М. Организация медицинского обеспечения больных с патологией системы кровообращения / Т. М. Максимова, Н. П. Лушкина, Е. Е. Борисова, Е. В. Огрызко // Пробл. социальной гигиены, здравоохранения иистории медицины. 2009. — № 1. — С. 32−35.
- Малютина, С. К. Проспективное изучение вклада артериальной гипергензии в риск развития сердечно-сосудистых событий / С. К. Малютина, Г. И. Симонова, В. В. Гафаров, Е. Г. Веревкин //Бюл. Сибир. отд-ния Рос. Акад. мед. наук. -2003. № 4. — С. 6−10.
- Мамедов, М.Н. Суммарный сердечно-сосудистый риск: от теории к практике / М. Н. Мамедов, H.A. Чепурина. М., 2012. — 42 с.
- Медико-демографические показатели Российской Федерации 2006. Статистические материалы. -М., 2007. 179 с.
- Моргунова, И.Е. Социальная значимость атеросклероза и роль полиненасыщенных жирных кислот в его лечении / И. Е. Моргунова // Рус. мед. журн. 2007. — Т. 15, № 20.-С. 1501−1504.
- Национальные клинические рекомендации Всероссийского научного общества кардиологов (ВНОК) / под ред. Р. Г. Оганова, М. Н. Мамедова. М., 2009. — 528 с.
- Небиеридзе, Д.В. Изучение гипотензивного эффекта правастатина у больных мягкой артериальной гипертонией и гиперхолестеринемией / Д. В. Небиридзе, ИА. Тваладзе, В, А Выгодин и др. // Кардиоваскулярная терапия и профилактика. -2002. № 1. — С. 22−27.
- Никитин, Ю.П. Новые фундаментальные и прикладные основы атерогенеза // Бюллетень Сибирского отделения Российской Академиинаук. 2006. — № 2. — С. 6−14.
- Никульчева, Н.Г. Фенотипирование дислипопротеидемий : методические рекомендации / Н. Г. Никульчева, И.В. Криворученко- под ред. А. Н. Климова, И. Е. Ганелиной. М., 1984. — С. 26−47.
- Оганов, Р.Г. Возможности использования модели SCORE в клинической практике / Р. Г. Оганов, Д. В. Небиеридзе // Кардиоваскулярная терапия и профилактика. 2007. — № 1. — С. 125.
- Оганов, Р.Г. Концепция факторов риска как основа профилактики сердечнососудистых заболеваний / Р. Г. Оганов // Врач. 2001. — № 7. — С. 3−6.
- Оганов, Р.Г. Профилактика сердечно-сосудистых заболеваний: пути развития / Р. Г. Оганов, Н. Ф. Герасименко, Г. В. Погосова, И. Е. Колтунова // Кардиоваскулярная терапия и профилактика. 2011. — Т. 10, № 3. — С. 5−7.
- Оганов, Р.Г. Эпидемию сердечно-сосудистых заболеваний можно остановить усилением профилактики / Р. Г. Оганов, Г. Я. Масленникова Профилактическая медицина. 2009. — № 6. — С. 3−7.
- Оганов, Р.Г. Эффективные стратегии длительного контроля неинфекционных заболеваний в России / Р. Г. Оганов, Г. Я. Масленникова // Профилактика заболеваний и укрепление здоровья. 2004. — № 1. — С. 3−6.
- Петрищев, H.H. Диагностическая ценность определения десквамированных эндотелиальных клеток в крови / H.H. Петрищев, O.A. Беркович, Т. Д. Власов, Е. В. Волкова, Е. Е. Зуева, Е. В. Мозговая // Клин, лабор. диагностика. 2001.-№ 1.-С. 50−52.
- Пилипчак, О. М. Фактор риска при ишемической болезни сердца сезонная адаптация к холоду / О. М. Пилипчак, Т. С. Брюзгина // Клиническая лабораторная диагностика. — 2006. — № 5. — С. 19−21.
- Погосова, Н.В. Эффективная профилактика сердечно-сосудистых заболеваний ключевой путь к улучшению демографической ситуации //
- Медицинский вестник. 2008. -№ 17/18. — С. 9−10. 5||Руководство по лечению дислипидемий (ЕКО, ЕОА) (European Heart Journal. — 2011. — Vol. 32. — P. 1769−1818 // Атеросклероз и дислипидемии. -2011. -N 4.-69 с.
- Руководство по медицинской профилактике / под ред. Р. Г. Оганова, P.A. Хальфина. М., 2007. — 450 с. — (Национальный проект «Здоровье»).
- Симонова, Г. И. Артериальная гипертония и риск сердечно-сосудистой смертности в городской сибирской популяции / Г. И. Симонова, Ю. П. Никитин, О. М. Глушанина и др. // Бюл. Сибир. отд-ния Рос. Акад. мед. наук. 2006. — N 4. — С. 88−92.
- Скворцова, В.И. Генетика ишемического инсульта / В. И. Скворцова, С. А. Лимборская, П. А. Сломинский и др. // Журн. неврологии и психиатрии им. С. С. Корсакова. Прил. «Инсульт». 2001. — № 4. — С. 10−17.
- Тишук, Е.А. Современное состояние и особенности заболеваемости населения Российской Федерации / Е. А. Тишук // Профилактика заболеваний и укрепление здоровья. 2009. -№ 1. — С. 3−13.
- Тожиев, М.С. Распространенность сердечно-сосудистых заболеваний, факторы риска, эффективность многофакторной профилактики / М. С. Тожиев, Д. Б. Шестов, AM. Воробьев и др. // Здравоохранение Российской Федерации. 2000. — № 3. — С. 6−9.
- Указ Президента РФ № 849 «О полномочном представителе Президента Российской Федерации в федеральном округе», 2000.
- Чазов, Е.И. Проблемы лечения больных ишемической болезнью сердца / Е. И. Чазов // Терапевтич. архив. 2000. — № 9. — С. 5−9.
- Чепурина, H.A. Суммарный сердечно-сосудистый риск: что знают врачи? / H.A. Чепурина, A.M. Калинина, М. Б. Худяков, Н. В. Киселева // Кардиоваскулярная терапия и профилактика. 2010. — Т. 9, № 5. — С. 18−23.
- Шальнова, С.А. Здоровье российских врачей. Клинико-эпидемиологическийанализ / С. А. Шальнова, Р. Г. Оганов, А. Д. Деев, С. К. Кукушкин // Кардиоваскулярная терапия и профилактика. 2008. — № 6. — С. 24−30.
- Шальнова, С.А. Оценка и управление суммарным риском сердечно-сосудистых заболеваний у населения России / С. А. Шальнова, Р. Г. Оганов, А. Д. Деев // Кардиоваскулярная терапия и профилактика. 2004. — № 3 (4). — С. 4−11.
- Шальнова, С.А. Оценка суммарного риска сердечно-сосудистых заболеваний / С. А. Шальнова, О. В. Вихирева // Рациональная фармакотерапия в кардиологии. 2005. — № 3. — С. 54−56.
- Шальнова, С.А. Мониторинг факторов риска хронических неинфекционных заболеваний в практическом здравоохранении профессор / С. А. Шальнова, A.M. Концевая // ГНИЦ. М, 2012. — 30 с.
- Щепин, О.П. Здоровье населения основа развития здравоохранения / О. П. Щепин, Р. В. Коротких, В. О. Щепин, В. А. Медик. — М, 2009. — 376 с.
- Щепин, О.П. Роль профилактических мероприятий в укреплении здоровья населения России / О. П. Щепин, Р. В. Коротких, Ю. Г. Трегубов, Д. В. Голикова // Пробл. социальной гигиены, здравоохранения и истории медицины. 2010. — № 4. — С. 3−7.
- Шляхто, Е.В. Комбинированная антигипертензивная терапия -современный взгляд на проблему / Е. В. Шляхто, А. О. Конради // Кардиоваскулярная терапия и профилактика. 2004. — Т. З, № 4. — С. 12−19.
- Шляхто, Е. В. Влияние гиполипидемической терапии на эндотелиальную дисфункцию у больных, перенесших инфаркт миокарда в молодом возрасте
- Е.В. Шляхто, Е. А. Баженова, О. А. Беркович, Е. В. Волкова, И. А. Толстова, М. 3. Алугишвили // Терапевтический архив. 2001. — Т.73, № 9 — С. 46−50.
- Abd, Т.Т. The role of C-reactive protein as a risk predictor of coronary atherosclerosis: implications from the JUPITER trial / T.T. Abd, D.J. Eapen, A. Bajpai et al. // Curr Atheroscler Rep. 2011. — Vol. 13, N 2. — P. 154−161.
- Abedin, M. Vascular calcification. Mechanisms and clinical ramifications / M. Abedin, Y. Tintut, L.L. Demer // Arterioscler Thromb Vase Biol. 2004. — Vol. 24. — P. 1161−1170.
- Achike, F.I. Obesity, metabolic syndrome, adipocytes and vascular function: A holistic viewpoint / F.I. Achike, N.H. To, H. Wang, C.Y. Kwan // Clin Exp Pharmacol Physiol. 2011. — Vol. 38, N l.-P. 1−10.
- Adachi, T. Neopterin is associated with plaque inflammation and destabilisation in human coronary atherosclerotic lesions / T. Adachi, T. Naruko, A. Itoh et al. // Heart. 2007. — Vol. 93.-P. 1537−1541.
- Adorni, M.P. The roles of different pathways in the release of cholesterol from macrophages / M.P. Adorni, F. Zimetti, J.T. Billheimer et al. // J Lipid Res. -2007. Vol. 48. — P. 2453−2462.
- Ait-Oufella, H. Recent advances on the role of cytokines in atherosclerosis / H. Ait-Oufella, S. Taleb, Z. Mallat, A. Tedgui // Arterioscler Thromb Vase Biol. -2011.-Vol. 31, N5.-P. 969−979.
- Allahverdian, S. Cholesterol homeostasis and high-density lipoprotein formation in arterial smooth muscle cells / S. Allahverdian, G. A Francis // Trends Cardiovasc Med. 2010. — Vol. 20, N 3. — P. 96−102.
- Alwaili, K. High-density lipoproteins and cardiovascular disease / K. Alwaili, Z. Awan, A. Alshahrani, J. Genest//Expert Rev Cardiovasc Ther. -2010. Vol. 8. -N 3. -P. 413−423.
- Anderson, K.M. An updated coronary risk profile. A statement for health professionals / K.M. Anderson, P.W. Wilson, P.M. Odell, W.B. Kannel //
- Circulation. 1991. — Vol. 83. — P. 356−362.
- Anderson, K.M. Cardiovascular disease risk profiles / K.M. Anderson, P.M. Odell, P.W.F. Wilson et al. // Am Heart J. 1990. — Vol. 121. — P. 293−298.
- Anghel, L. Dislypidemia as a risk factor for cardiovascular disease / L. Anghel, R. Ghiuru, C.M. Gavrilescu // Rev Med Chir Soc Med Nat Iasi. 2010. — Vol. 114, N 4. — P. 977−981.
- Ariesen, M.J. Risk Factors for Intracerebral Hemorrhage in the General Population. A Systematic Review / M.J. Ariesen, S.P. Claus, G.J.E. Rinkel, A. Algra // Stroke. 2003. — Vol. 34, N 8. — P. 2060−2065.
- Armstrong, D.W. The effect of the change in the Framingham Risk Score calculator between the 2006 and 2009 Canadian lipid guidelines / D.W. Armstrong, D. Brouillard, M.F. Matangi // Can J Cardiol. 2011. — Vol. 27, N 2. — P. 167−70.
- Arnal, J.F. Estrogens and atherosclerosis / J.F. Arnal, P. Gourdy, R. Elhage et al. // Eur J Endocrinol. 2004. — Vol. 150, N 2. — P. 113−117.
- Aslam, F. Hyperlipidemia in older adults / F. Aslam, A. Haque, L.V. Lee, J. Foody // Clinics in Geriatric Medicine. 2009. — Vol. 25, N 4. — P. 591−606.
- Aslibekyan, S. Development of a Cardiovascular Risk Score for Use in Low- and Middle-Income Countries / S. Aslibekyan, H. Campos, E.B. Loucks et al. // J Nutr. 2011. — Epub ahead of print.
- Assmann, G. Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Miinster (PROCAM) Study / G. Assmann, H. Schulte, P. Cullen, U. Seedorf// Eur J Clin Invest. 2007. — Vol. 37. — P. 925−932.
- Assmann, G. Coronary heart disease: reducing the risk: a worldwide view. International Task Force for the Prevention of Coronary Heart Disease / G. Assmann, R. Carmena, P. Cullen et al. // Circulation. 1999. — Vol. 100, N 18. — P. 1930−1938.
- Assmann, G. The Miinster Heart Study (PROCAM): results of follow-up at 8 years / G. Assmann, P. Cullen, H. Schulte //Eur Heart J. -1998. Vol. 19, Suppl A. -P. A2-A11.
- Avanzas, P. Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris / P. Avanzas, R. Arroyo-Espliguero, J. Quiles et al. // Eur Heart J. 2005. — Vol. 26. — P. 457−463.
- Avanzas, P. Neopterin for risk assessment in angina pectoris / P. Avanzas, J.C. Kaski // Drug News Perspect. 2009. — Vol. 22, N 4. — P. 215−219.
- Avignon, A. Osteoprotegerin: A Novel Independent Marker for Silent Myocardial Ischemia in Asymptomatic Diabetic Patients / A. Avignon, A. Sultan, C. Piot et al. // Diabetes Care. 2007. — Vol. 30. — P. 2934−2939.
- Baker, R.G. NF-kB, inflammation, and metabolic disease / R.G. Baker, M.S. Hayden, S. Ghosh//Cell Metab. 2011.-Vol. 13. N1.-P. 11−22.
- Barton, M. Obesity and Risk of Vascular Disease: Importance of Endothelium-Derived Vasoconstriction / M. Barton, O. Baretella, M.R. Meyer // Br J Pharmacol. 2011. — Epub ahead of print.
- Basu, S. Bioactive eicosanoids: role of prostaglandin F (2a) and F2-isoprostanes in inflammation and oxidative stress related pathology / S. Basu // Mol Cells.-2010.-Vol. 30, N5.-P. 383−391.
- Baudin, B. The vascular origin of coordinates is determined angiotensin I expression of an enzyme with conversion in endothelial cells / B. Baudin, M.
- Berard, J.L. Carrier et al. // Hypertension. 1997. — Vol. 29. — P. 124−131.
- Bays, H.E. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications / H.E. Bays, A.P. Tighe, R. Sadovsky, M.H. Davidson // Exp Rev Cardiovasc Ther. 2008. — Vol. 6. — P. 391−409.
- Bazzano, L.A. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States / L.A. Bazzano, J. He, P. Muntner et al. // Ann. Intern. Med. 2003. — Vol. 138, N 11.-P. 891−897.
- Beaghol, R. Cardiovascular diseases: causes, surveillance and prevention / R. Beaghol, R. Saracci, S. Panico // Int J Epidemiol. 2001. — Vol. 30. — P. 1−4.
- Beaumont, J.L. Classification of hyperlipidemias and hyperlipoproteinemias / J.L. Beaumont, L.A. Carlson, G. R Cooper et al. //Bull. Wld. Health Org. -1970. Vol. 43. -P. 891−915.
- Behrendt, D. Endothelial function: from vascular biology to clinical applications / D. Behrendt, P. Ganz // Am. J. Cardiol. 2002. — Vol. 90 (Suppl.). — P. 40L-48L.
- Bennett, B.J. Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice / B.J. Bennett, M. Scatena, E.A. Kirk et al. // Arterioscler Thromb Vase Biol. 2006. — Vol. 26. — P. 2117−2124.
- Benschop, R.J. The effects of beta-adrenoceptor stimulation on adhesion of human natural killer cells to cultured endothelium / Benschop R.J., Nijkamp F.P., Ballieux R.E., Heijnen C.J.//Br J Pharmacol.-1994.-Vol. 113(4).-P. 1311−1316.
- Bermudez, B. Oleic Acid in olive oil: from a metabolic framework toward a clinical perspective / B. Bermudez, S. Lopez, A. Ortega et al. // Curr Pharm Des. -2011.-Vol. 17, N8.-P. 831−843.
- Boland, B.J. CAD risk assessment must start before the age of 50 years / B.J. Boland, R. De Muylder, G. Goderis, J. Degryse // BMJ. 2003. — Vol. 326. — P. 1436.
- Bombeli, T. Cyclosporine-induced detachment of vascular endothelial cells initiates the intrinsic coagulation system in plasma and whole blood / T. Bombeli, M. Muller, P.W. Straub, A. Haeberli // J Lab Clin Med. 1996. — Vol. 127. — P. 621−634.
- Boo, S. Coronary heart disease risk estimation in asymptomatic adults / S. Boo, C.M. Waters, E.S. Froelicher //Nurs Res. -2012. Vol. 61(1). — P. 66−9.
- Bouvier, C.A. Circulating endothelium as an indication of vascular injury / C.A. Bouvier, E. Gaynor, J.R. Cintron et al. // Thromb. Diath. Haemorrh. 1970. -Vol. 40 (Suppl.).-P. 163−168.
- Boyle, W.J. Osteoclast differentiation and activation / W.J. Boyle, W.S. Simonet, D.L. Lacey // Nature. 2003. — Vol. 423. — P. 337−342.
- Brindle, P. Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: A systematic review / P. Brindle, A. Beswick, T. Fahey, S. Ebrahim // Heart. 2006. — Vol. 92. — P. 1752−1759.
- Brindle, P. Predictive accuracy of the Framingham Coronary Risk Score in British Men prospective cohort study / P. Brindle, J. Emberson, F. Lample et al. // BMJ. 2003. — Vol. 327. — P. 1267−1270.
- Brindle, P. Primary prevention of coronary heart disease / P. Brindle, T. Fahey // BMJ. 2002. — Vol. 325. — P. 56−57.
- Browner, W.S. Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women / W.S. Browner, L.Y. Lui, S.R. Cummings // J Clin Endocrinol Metab. 2001. — Vol. 86. — P. 631−637.
- Brunham, L.R. Variations on a Gene: Rare and Common Variants in ABCA1 and Their Impact on HDL Cholesterol Levels and Atherosclerosis / L.R. Brunham, R.R. Singaraja, M.R. Hayden // Ann Rev Nutr. 2006. — Vol. 26. — P. 105−129.
- Call, J.T. Focusing on inflammation in the treatment of atherosclerosis / J.T. Call,
- E.N. Deliargyris, L.K. Newby // Cardiol Rev. 2004. — Vol. 12, N 4. — P. 194−200.
- Capaldo, B. Abnormal Vascular Reactivity in Growth Hormone Deficiency / B. Capaldo, V. Guardasole, F.Pardoetal.//Circulation.-2001.-Vol. 103, N4.-P. 520−524.
- Caprioli, A. Blood-borne seeding by hematopoietic and endothelial precursors from the allantois / A. Caprioli, T. Jaffredo, R. Gautier et al. // Proc. Natl. Acad. Sci. USA. 1998. — Vol. 95, N 4. — P. 1641−1646.
- Castaigne, A. Lifestyle and cardiovascular risk / A. Castaigne, D. Pouchain // Rev Prat. -2005. Vol. 55(16). — P. 1795−804.
- Ceska, R. Dyslipidemia and obesity 2011. Similarities and differences / R. Ceska, M. Vrablik, P. Sucharda // Vnitr Lek. 2011. — Vol. 57, N 3. — P. 248−253.
- Chan, D.C. Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies / D.C. Chan, G.F. Watts // Expert Opin Pharmacother. 2011. -Vol. 12.-P. 13−30.
- Chateau-Degat, M.L. Obesity risks: towards an emerging Inuit pattern / M.L. Chateau-Degat, E. Dewailly, G. Charbonneau et al. // Int J Circumpolar Health. -2011.-Vol. 70, N2.-P. 166−177.
- Chelland Campbell, S. Smoking and smoking cessation the relationship between cardiovascular disease and lipoprotein metabolism: a review / S. Chelland Campbell, R.J. Moffatt, B.A. Stamford // Atherosclerosis. 2008. — Vol. 201. — P. 225−235.
- Chiysant, S.G. A new paradigm in the treatment of the cardiovascular disease continuum: focus on prevention/S.G. Chiysant//Hippokratia.-2011. Vol. 15 (l).-P. 7−11.
- Chow, S.E. Oxidized LDL promotes vascular endothelial cell pinocytosis via a prooxidation mechanism / S.E. Chow, R.S. Lee, S.H. Shih, J.K. Chen // FASEB J. 1998. — Vol. 12, N 10. — P. 823−830.
- Chuang, C.C. Potential Mechanisms by Which Polyphenol-Rich Grapes Prevent Obesity-Mediated Inflammation and Metabolic Diseases / C.C. Chuang, M.K. Mcintosh // Ann Rev Nutr. 2011. — Epub ahead of print.
- Chudyk, A Effects of Exercise on Cardiovascular Risk Factors in Type 2 Diabetes: A metaanalysis / A. Chudyk, RJ. Petrella // Diabetes Care. 2011. — Vol. 34, N 5. -P. 1228−1237.
- Chyou, P.H. Serum cholesterol concentrations and all-cause mortality in older people / P.H. Chyou, E.D. Eaker // Age and Ageing. 2000. — Vol. 29. — P. 69−74.
- Cines, DB. Endothelial cells in physiology and in the pathophysiology of vascular disorders / D.B. Cines, E.S. Pollak, C.A. Buck et al. //Blood. -1998. Vol. 91. -P. 3527−3561.
- Claise, C. Oxidized-LDL induce apoptosis in HUVEC but not in the endothelial cell / C. Claise, M. Edeas, N. Chaouchi et al. // Atherosclerosis. -1999. Vol. 147. — P. 95−104.
- Clancy, R. Circulating activated endothelial cells in systemic lupus erythematosus: further evidence for diffuse vasculopathy / C. Claise, M. Edeas, N. Chaouchi et al. // Arthritis Rheum. 2001. — Vol. 44. — P. 1203−1208.
- Clearfield, M.B. Altering the pathophysiology of atherosclerosis: the multidimensional role of statins / M.B. Clearfield // J Am Osteopath Assoc. -2010 Vol. 110, N 4, Suppl 4. P. S2-S6.
- Cohen, A.W. Role of Caveolae and Caveolins in Health and Disease / A.W. Cohen, R. Hnasko, W. Schubert, M.P. Lisanti //Physiol. Rev. 2004. — Vol. 84. -P. 1341−1379.
- Collin-C)sdoby, P. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin/P. Collin-Osdoby// Circ Res. -2004. Vol. 95. -P. 1046−1057.
- Conroy, R.M. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project / R.M. Conroy, K. Pyorala, A.P. Fitzgerald et al. // Eur Heart J. 2003. — Vol. 24, N 11. — P. 987−1003.
- Cooney, M.T. How much does HDL cholesterol add to risk estimation? A report from the SCORE Investigators / M.T. Cooney, A. Dudina, D. De Bacquer et al. // Eur J Cardiovasc Prev Rehabil. 2009. — Vol. 16, N 3. — P. 304−314.
- Corretti, M. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery / M. Corretti, T.J. Anderson, E.J. Benjamin, et al. // J. Am. Coll. Cardiol. 2000. — Vol. 39. — P. 257−265.
- Crosby, J.R. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation / J.R. Crosby, W.E. Kaminski, G. Schatteman et al. // Circ Res. 2000. — Vol. 87. — P. 728−730.
- Dabhadkar, K.C. Prospects for a Cardiovascular Disease Prevention Polypill / K.C. Dabhadkar, A. Kulshreshtha, M.K. Ali, K.M. Venkat Narayan // Ann Rev Public Health. 2011. — Vol. 32. — P. 23−38.
- D’Agostino, R.B.Sr. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation / R.B.Sr.
- D’Agostino, S. Grundy, L.M. Sullivan, P. Wilson- CHD Risk Prediction Group // JAMA. 2001. — Vol. 286, N 2. — P. 180−187.
- Damani, S., Characterization of Circulating Endothelial Cells in Acute Myocardial Infarction / S. Damani, A. Bacconi, O. Libiger // Sci Transl Med. -2012.-Vol. 21, N4(126).-P. 126- 133.
- Damas, J.K. Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets / J.K. Damas, T. Waehre, A. Yndestad et al. // Circulation. 2003. — Vol. 107, N 21. — P. 2670−2676.
- Danesh, J. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease / J. Danesh, J.G. Wheeler, G.M. Hirschfield et al. // N Engl J Med. 2004. — Vol. 350. — P. 1387−1397.
- Das, D.K. Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose / D.K. Das, J. Dudley, S. Das, S. Mukheijee // J Nutr Biochem. 2009. — Vol. 20. — P. 443−452.
- Davidson, M.H. Therapies targeting exogenous cholesterol uptake: new insights and controversies / M.H. Davidson // Curr Atheroscler Rep. 2011. -Vol. 13, N 1. — P. 95−100.
- Daviglus, M.L. Preventing cardiovascular disease in the 21st century: therapeutic and preventive implications of current evidence / M.L. Daviglus, D.M. Lloyd-Jones, A. Pirzada // Am J Cardiovasc Drugs. 2006. — Vol. 6. — P. 87−101.
- Davignon, J. Role of endothelial dysfunction in atherosclerosis / J. Davignon, P. Ganz // Circulation. 2004. — Vol. 109 (Suppl. 3). — P. III27-III32.
- De Caterina, R. Pharmacological modulation of vascular inflammation in atherothrombosis / R. De Caterina, M. Massaro, E. Scoditti, M. Annunziata
- Carluccio // Ann N Y Acad Sci. 2010. — Vol. 1207. — P. 23−31.
- Deckert, A. Time trends in cardiovascular disease mortality in Russia and Germany from 1980 to 2007 are there migration effects? / A. Deckert, V. Winkler, A. Paltiel et al. // BMC Public Health. — 2010. — Vol. 10. — P. 488.
- Demer, L.L. Skeleton key to vascular disease / L.L. Demer, M. Abedin // J Am Coll Cardiol. 2004. — Vol. 44. — P. 1977−1999.
- Devaraj, S. Statin therapy in metabolic syndrome and hypertension postJUPITER: what is the value of CRP? / S. Devaraj, D. Siegel, I. Jialal // Curr Atheroscler Rep.-2011.-Vol. 13, N l.-P. 31−42.
- Dias, R.G. Nitric oxide and the cardiovascular system: cell activation, vascular reactivity and genetic variant / R.G. Dias, C.E. Negrao, M.H. Krieger // Arq Bras Cardiol. 2011. — Vol. 96, N 1. — P. 68−75.
- Dignat-George, F. Circulating endothelial cells in vascular disorders: new insights into an old concept / F. Dignat-George, J. Sampol // Eur J Haematol. -2000.-Vol. 65.-P. 215−220.
- Dimmeler, S. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway / S. Dimmeler, A. Aicher, M. Vasa et al. // J Clin Invest. 2001. — Vol. 108. — P. 391−397.
- D’Onise, K. The beneficial effects of preschool attendance on adult cardiovascular disease risk / K. D’Onise, J.W. Lynch, R.A. McDermott, A. Esterman // Aust N Z J Public Health. 2011. — Vol. 35, N 3. — P. 278−283.
- Douketis, J.D. Canadian guidelines for body weight classification in adults: application in clinical practice to screen for overweight and obesity and to assess disease risk / J.D. Douketis, G Paradis, H. Keller // CMAJ. 2005. — Vol. 172. — P. 995−998.
- Downs, J.R. Primary prevention of acute coronary events with lovastatin in men and in women with average cholesterol levels: results of AFCAPS/TexCAPS / J.R. Downs, M. Clearfild, S. Weis et al. //JAMA. 1998. — Vol. 279. -P. 1615−1622.
- Ebrahim, S. Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease / S. Ebrahim, G.D. Smith // Br. Med. J. 1997. — Vol. 314. — P. 1666−1674.
- Eichler, K. Prediction of first coronary events with the Framingham score: a systematic review / K. Eichler, M.A. Puhan, J. Steurer, L.M. Bachmann // Am Heart J. 2007. -. Vol. 153(5). — P. 722−31, 731. el-8.
- El Hadj Othmane, T. Osteoprotegerin: regulator, protector and marker / T. El Hadj Othmane, G. Speer, B. Fekete et al. // Orv Hetil. 2008. — Vol. 149, N 42. — P. 1971−1980.
- El Haouari, M. Modulation of platelet function and signaling by flavonoids / M. El Haouari, J.A. Rosado // Mini Rev Med Chem. 2011. — Vol. 11, N 2. — P. 131 -142.
- Emberson, J. Evaluating the impact of population and high-risk strategies forthe primary prevention of cardiovascular disease / J. Emberson, P. Whincup, R. Morris et al. // Eur Heart J. 2004. — Vol. 25. — P. 484−491.
- Endo, J. Roles of lipid mediators in controlling vascular inflammation and the progression of atherosclerosis / J. Endo, M. Arita // Nippon Rinsho. 2011. -Vol. 69, N1.-P. 34−38.
- Engberg, M. General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5-year follow-up / M. Engberg, B. Christensen, B. Karlsmose et al. // J Fam Pract. 2002. — Vol. 51. — P. 546−552.
- Eriksson, M. Blood lipids in 75 048 type 2 diabetic patients: a population-based survey from the Swedish National diabetes register / M. Eriksson, B. Zethelius, K. Eeg-Olofsson et al. // Eur J Cardiovasc Prev Rehab. 2011. — Vol. 18. — P. 97−105.
- Espinola-Klein, C. Inflammatory markers and cardiovascular risk in the metabolic syndrome / C. Espinola-Klein, T. Gori, S. Blankenberg, T. Munzel // Front Biosci. -2011. -Vol. 16.-P. 1663−1674.
- Evans, C.D. Diabetes and cardiovascular disease interventions by community pharmacists: a systematic review / C.D. Evans, E. Watson, D.T. Eurich et al. // Ann Pharmacother. 2011. — Vol. 45, N 5. — P. 615−628.
- Evans, M. Total lipid management and residual risk: beyond statin therapy / M. Evans//Br J Hosp Med (Lond). 2011. — Vol. 72(3). — P. 132−136.
- Everson-Rose, S.A. Psychosocial factors and cardiovascular diseases / S.A. Everson-Rose, T.T. Lewis // Ann Rev Public Health. 2005. — Vol. 26. — P. 469−500.
- Fagard, R.H. Exercise therapy in hypertensive cardiovascular disease / R.H. Fagard // Prog Cardiovasc Dis. 2011. — Vol. 53, N 6. — P. 404−411.
- Farbstein, D. Antioxidant vitamins and their use in preventing cardiovascular disease / D. Farbstein, A. Kozak-Blickstein, A.P. Levy // Molecules. 2010. -Vol. 15, N 11.-P. 8098−8110.
- Fazio, G. Atherosclerosis, inflammation and Chlamydia pneumoniae / G. Fazio, M. Giovino, A. Gullotti et al. // World J Cardiol. 2009. — Vol. 1, N 1. — P. 31 -40.
- Feletou, M. TP receptors and oxidative stress hand in hand from endothelial dysfunction to atherosclerosis / M. Feletou, R.A. Cohen, P.M. Vanhoutte, T.J. Verbeuren // Adv Pharmacol. 2010. — Vol. 60. — P. 85−106.
- Feron, O. Hydroxy-methylglutaiyl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance / O. Feron, C. Dessy, J.P. Desager et al.// Circulation.-2001.-Vol. 103, N l.-P. 113−118.
- Filion, K.B. Omega-3 fatty acids in high-risk cardiovascular patients: a metaanalysis of randomized controlled trials / K.B. Filion, F. El Khoury, M. Bielinski et al. // BMC Cardiovascular Disorders. 2010. — N 7. — P. 10−24.
- Finkel, T. Oxygen radicals and signaling / T. Finkel // Current Opinion in Cell Biology. 1998. — Vol. 10. — P. 248−253.
- Fitzpatrick, L.A. Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis / L.A. Fitzpatrick, A. Severson, W.D. Edwards, R.T. Ingram // J Clin Invest. 1994. — Vol. 94. — P. 1597−1604.
- Fletcher, G.F. Exercise in the prevention of stroke / G.F. Fletcher // Health Rep.- 1994.-Vol. 6.-P. 106−110.
- Fornoni, A. Metabolic syndrome and endothelial dysfunction / A. Fornoni, L. Raij // Current Hypertension Reports. 2005. — Vol. 7. — P. 88−95.
- Franco, O.H. Primary prevention of cardiovascular disease: cost-effectiveness comparison / O.H. Franco, A.J. der Kinderen, C. De Laet et al. // Int J Technol Assess Health Care. 2007. — Vol. 23. — P. 71−79.
- Fredrickson, D.S. Fat transport mechanism and disorders / D.S. Fredrickson, R.I. Levy, R.S. Lees // N. Engl. J. Med. 1967. — Vol. 276. — P. 33−34.
- Friedwald, W.T. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge / W.T.
- Friedwald, R.I. Lavy, D.S. Fredrickson // Clin. Chem. 1972. — Vol. 18. — P. 499−502.
- Frikke-Schmidt, R. Genetic variation in the ABCA1 gene, HDL cholesterol, and risk of ischemic heart disease in the general population / R. Frikke-Schmidt // Atherosclerosis. 2010. — Vol. 208. — P. 305−316.
- Fuchs, D. The role of neopterin in atherogenesis and cardiovascular risk assessment / D. Fuchs, P. Avanzas, R. Arroyo-Espliguero et al. // Curr Med Chem. 2009. — Vol. 16, N 35. — P. 4644−4653.
- Galkina, E. Immune and Inflammatory Mechanisms of Atherosclerosis / E. Galkina, K. Ley // Ann Rev Immunol. 2009. — Vol. 27. — P. 165−197.
- Gannage-Yared, M.H. Relation between androgens and cardiovascular risk factors in a young population / M.H. Gannage-Yared, R. Chedid, L. Abs // Clin Endocrinol (Oxf). -2011. Vol. 74, N 6. — P. 720−725.
- Gao, X. High density lipoproteins-based therapies for cardiovascular disease / X. Gao, S. Yuan // J Cardiovasc Dis Res. 2010. — Vol. 1, N 3. — P. 99−103.
- Garcia-Moll, X. Increased serum neopterin: a marker of coronary artery disease activity in women / X. Garcia-Moll, D. Cole, E. Zouridakis, J.C. Kaski // Heart. -2000.-Vol. 83.-P. 346−350.
- Garcia-Moll, X. Serum neopterin and complex stenosis morphology in patients with unstable angina / X. Garcia-Moll, F. Coccolo, D. Cole, J.C. Kaski // Am Coll Cardiol. 2000. — Vol. 2, N 35. — P. 956−962.
- Gaziano, T.A. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis / T.A. Gaziano, L.H. Opie, M.C. Weinstein // Lancet. 2006. — Vol. 368. — P. 679−686.
- George, F. Cytofluorometric detection of human endothelial cells in whole blood using S-Endo 1 monoclonal antibody / F. George, P. Poncelet, J.C. Laurent et al. //J Immunol Methods. 1991. — Vol. 139. — P. 65−75.
- Gersh, B.J. Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications / B.J. Gersh, K. Sliwa, B.M. Mayosi, S. Yusuf // Eur Heart J. 2010. — Vol. 31, N 6. — P. 642−648.
- Getz, G.S. High-density lipoprotein function in regulating insulin secretion: possible relevance to metabolic syndrome / G.S. Getz, C.A. Reardon // Arterioscler Thromb Vase Biol. 2010. — Vol. 30. — P. 1497−1499.
- Giacco, F. Oxidative stress and diabetic complications / F. Giacco, M. Brownlee//Circ Res. -2010. -Vol. 107, N9.-P. 1058−1070.
- Giannotti, G. Endothelial dysfunction as an early sign of atherosclerosis / G. Giannotti, U. Landmesser // Herz. 2007. — Vol. 32, N 7. — P. 568−572.
- Gill, M. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC 133(+) endothelial precursor cells / M. Gill, S. Dias, K. Hattorf et al.//Circ Res.-2001.-Vol. 88.-P. 167−174.
- Gkaliagkousi, E. Nitric oxide signalling in the regulation of cardiovascular and platelet function / E. Gkaliagkousi, A. Ferro // Front Biosci. 2011. — Vol. 16. — P. 1873−1897.
- Glassberg, H. Management of Lipids in the Prevention of Cardiovascular Events / H. Glassberg, D.J. Rader // Ann Rev Med. 2008. — Vol. 59. — P. 79−94.
- Gohlke, H. Primary prevention of coronary artery disease: Is there a role for risk scores? / H. Gohlke // Herz. 2012. — Vol. 37(1). — P.75−80.
- Golledge, J. Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis / J. Golledge, M. McCann, S. Mangan et al. // Stroke. 2004. — Vol. 35. — P. 1636−1641.
- Gonzalez, R. Effects of flavonoids and other polyphenols on inflammation / R. Gonzalez, I. Ballester, R. Lopez-Posadas et al. // Crit Rev Food Sei Nutr. 2011. -Vol. 51, N 4. — P. 331−362.
- Gotto, A.M.Jr. The ILIB Lipid Handbook for Clinical Practice. Blood Lipids and Coronary Heart Disease / A.M.Jr. Gotto, G. Assmann, R. Carmena et al. -2nd Edition. New York, 2000. — 248 p.
- Green, D.J. Effect of exercise training on endothelium-derived nitric oxide function in humans / D.J. Green, A. Maiorana, G. 0"Driscoll, R. Taylor // J. Physiol. 2004. — Vol. 256. — P. 1−25.
- Grefte, A. Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection / A. Grefte, M. van der Giessen, W. van Son, T.H. The // J Infect Dis. 1993. — Vol. 167. — P. 270−277.
- Gremese, E. The metabolic syndrome: The crossroads between rheumatoidarthritis and cardiovascular risk / E. Gremese, G. Ferraccioli // Autoimmun Rev. -2011. Epub ahead of print.
- Grover, S.A. Preventing cardiovascular disease among Canadians: what are the potential benefits of treating hypertension or dyslipidemia? / S.A. Grover, L. Coupal, M. Kaouache, I. Lowensteyn // Can J Cardiol. 2007. — Vol. 23. — P. 467−473.
- Grundy, S.M. Definition of Metabolic Syndrome / S.M. Grundy, H.B. Brewer, J. I Cleeman et al. // Circulation. 2004. — Vol. 109. — P. 433−438.
- Grundy, S.M. Obesity, metabolic syndrome, and coronary atherosclerosis / S.M. Grundy // Circulation. 2002. — Vol. 105. — P. 2696−2698.
- Grundy, S.M. Primary Prevention of Coronary Heart Disease. Integrating Risk Assessment With Intervention / S.M. Grundy//Circulation.-1999.-Vol. 100, N9.-P. 988−998.
- Guo, S.S. Aging, body composition, and lifestyle: the Fels Longitudinal Study / S.S. Guo, C. Zeller, W.C. Chumlea, R.M. Siervogel // American Journal of Clinical Nutrition. 1999. — Vol. 70, N 3. — P. 405−411.
- Gupta, S. Serum neopterin in acute coronary syndromes / S. Gupta, S. Fredericks, R.A. Schwartzman et al. // Lancet. 1997. — Vol. 349. — P. 1252−1253.
- Haas, M J. Inflammation, high-density lipoprotein and cardiovascular dysfunction / M.J. Haas, A.D. Mooradian // Curr Opin Infect Dis. 2011. — Vol. 24, N 3. — P. 265−272.
- Hacihamdioglu, B. Abdominal obesity is an independent risk factor for increased carotid intima- media thickness in obese children / B. Hacihamdioglu, V. Okutan, Y. Yozgat et al. // Turk J Pediatr. 2011. — Vol. 53, N 1. — P. 48−54.
- Hamburg, N.M. Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits / N.M. Hamburg, G.J. Balady // Circulation. -2011.-Vol. 123, N1.-P. 87−97.
- Han, S.H. Sex differences in atheroma burden and endothelial function in patients with early coronary atherosclerosis / S.H. Han, J.H. Bae, D.R. Holmes et al.// Eur Heart J. -2008. -Vol. 29, N 11.-P. 1359−1369.
- Hans, T.S. Waist circumference in the indentification of cardiovascular risk factors: prevalence study in a randomized sample /T.S. Hans, E.M. Van Leer, J.C. Seidell, M.E. Lean // Br. Med. J. 1995. — Vol. 311. — P. 1401−1405.
- Hansson, G.K. Inflammation, atherosclerosis, and coronary artery disease / G.K. Hansson // N Engl J Med. 2005. — Vol. 352. — P. 1685−1695.
- Hansson, G.K. The immune system in atherosclerosis / G.K. Hansson, A. Hermansson //Nat Immunol. 2011. — Vol. 12, N 3. — P. 204−212.
- Harrison, D.G. Regulation of endothelial cell tetrahydrobiopterin pathophysiological and therapeutic implications / D.G. Harrison, W. Chen, S. Dikalov, L. Li // Adv Pharmacol. 2010. — Vol. 60. — P. 107−132.
- Hashimoto, M. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle / M. Hashimoto, M. Akishita et al.//Circulation.-2005.-Vol. 92.-P. 3431−3435.
- Havel, R.J. Triglyceride-rich lipoproteins and plasma lipid transport / R.J. Havel // Arterioscler Thromb Vase Biol. 2010. — Vol. 30. — P. 9−19.
- Heinrich, K.M. Multiple health behaviors in an ethnically diverse sample of adults with risk factors for cardiovascular disease / K.M. Heinrich, J. Maddock //
- Perm J.-2011.-Vol. 15, N l.-P. 12−18.
- Herrmann, J. The endothelium: Dysfunction and beyond / J. Herrmann, A. Lerman // Journal ofNuclear Cardiology. 2001. — Vol. 8. — P. 197−206.
- Hingorani, A.D. A simple program for guiding management of cardiovascular risk factors and prescribing / A.D. Hingorani, P. Vallance //BMJ. -1999. Vol. 318. -P. 101−105.
- Hladovec, J. Circulating endothelial cells as a sign of vessel wall lesions / J. Hladovec // Physiol. Bohemoslov. 1978. — Vol. 27, N 2. — P. 140−144.
- Hladovec, J. Circulating endothelial cells in acute myocardial infarction and angina pectoris / J. Hladovec, I. Prerovsky, V. Stanek, J. Fabian // Klin. Wochenschr. 1978. — Vol. 56. — P. 1033−1036.
- Hladovec, J. Circulating endothelial cells isolated together with platelets and the experimental modification of their count in rats / J. Hladovec, P. Rossmann // Thromb Res. 1973. — Vol. 3. — P. 663−674.
- Hoang, K.C. Global Coronary Heart Disease Risk Assessment of Individuals With the Metabolic Syndrome in the US / K.C. Hoang, H. Ghandehari, V.A. Lopez et al. // Diabetes Care. 2008. — Vol. 31. — P. 1405−1409.
- Hobson, B. Endothelial proliferation in tumours and normal tissues: continuous labelling studies / B. Hobson, J. Denekamp // Br J Cancer. -1984. Vol. 49. — P. 405−413.
- Hodoglugil, U. Polymorphisms in the hepatic lipase gene affect plasma HDL-cholesterol levels in a Turkish population / U. Hodoglugil, D.W. Williamson, R.W. Mahley // J Lipid Res. 2010. — Vol. 51. — P. 422−430.
- Hoekstra, M. Scavenger receptor BI: a multi-purpose player in cholesterol and steroid metabolism / M. Hoekstra, T.J. Van Berkel, M. Van Eck // World J Gastroenterol. 2010. — Vol. 16, N 47. — P. 5916−5924.
- Holecki, M. The influence of weight loss on serum osteoprotegerin concentration in obese perimenopausal women / M. Holecki, B. Zahorska
- Markiewicz, J. Janowska et al. // Obesity. 2007. — Vol. 15. — P. 1925−1929.
- Howard, R.J. Molecular studies related to the pathogenesis of cerebral malaria / R.J. Howard, A.D. Gilladoga // Blood. 1989. — Vol. 74. — P. 2603.
- Hu, Y. Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulation progenitor cells / Y. Hu, F. Davison, Z. Zhang, Q. Xu // Circulation. 2003. — Vol. 108. — P. 3122−3127.
- Hwang, J. Resveratrol protects ROS-induced cell death by activating AMPK in H9c2 cardiac muscle cells / J. Hwang, Y. Kwon, O.J. Park, M.S. Kim // Genes Nutr. 2008. — Vol. 2. — P. 323−326.
- Iijima, K. Can statins slow the process of vascular calcification? Possibilities of lipid-lowering therapy and pleiotropic effect by statin treatment / K. Iijima, Y. Ouchi//Clin Calcium.-2010.-Vol. 20, N 11.-P. 1719−1728.
- Ishibashi, T. Anti-atherosclerotic and anti-inflammatory effects of statin on cardiovascular disease and their mechanisms / T. Ishibashi // Nippon Rinsho. -2011.-Vol. 69, N 1. P. 79−84.
- Isles, C.G. Risk assessment in primary prevention of coronary heart disease: randomised comparison of three scoring methods / C.G. Isles, L.D. Ritchie, P. Murchie, J. Norrie // BMJ. 2000. — Vol. 320. — P. 690−691.
- Ito, M.K. Statins for cardiovascular prevention according to different strategies: a cost analysis / M.K. Ito, D. Nanchen, N. Rodondi et al. // American J of Cardiovascular Drugs. -2011. -Vol. 11, N l.-P. 33−44.
- Iwai, K. Arterial calcification and risk of cardiovascular events in diabetes mellitus / K. Iwai, S. Morimoto // Clin Calcium. 2010. — Vol. 20, N 11. — P. 1620−1625.
- Jackson, J.R. Estimating cardiovascular risk for primary prevention: outstanding questions for primary care / J.R. Jackson, K. Boomla, B. Hart, G. Feder // BMJ. 2000. — Vol. 320. — P. 702−704.
- Jander, S. Inflammation in high-grade carotid stenosis. A possible role for macrophages and T cells in plaque destabilization / S. Jander, M. Sitzer, R. Schumann et al. // Stroke. 1998. — Vol. 29. — P. 1625−1630.
- Jarvisalo, M.J. Assessment of inflammatory markers and endothelial function /
- M.J. Jarvisalo, M. Juonala, O.T. Raitakari // Curr Opin Clin Nutr Metab Care. -2006. Vol. 9, N 5. — P. 547−552.
- Jatoi, N.A. Impact of smoking and smoking cessation on arterial stiffness and aortic wave reflection in hypertension / N.A. Jatoi, P. Jerrard-Dunne, J. Feely, A. Mahmud // Hypertension. 2007. — Vol. 49, N 5. — P. 989−985.
- Jia, E.Z. Smoking and coronary atherosclerosis: follow-up study in China / E.Z. Jia, J. Liang, ZJ. Yang et al. // Clin Exp Pharmacol Physiol. 2009. — Vol. 36, N 7. — P. 690−695.
- Jono, S. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease / S. Jono, Y. Ikari, A. Shioi et al. // Circulation. 2002. — Vol. 106. — P. 1192−1194.
- Kaski, J. C. Neopterin: Still a Forgotten Biomarker / J. C. Kaski, P. Avanzas, R. Arroyo-Espliguero // Clinical Chemistry. 2005. — Vol. 51. — P. 1902−1903.
- Kausik, K. R. A Novel Marker of Monocyte Activation in Patients With Acute Coronary Syndrome // K. R. Kausik, D. A. Morrow, M. S. Sabatine, A. Shui, N. Rifai, C. P. Cannon, E. Braunwald // Circulation. 2007. — Vol. 115. — P. 3071−3078.
- Kawashima, S. Dysfunction of Endothelial Nitric Oxide Synthase and Atherosclerosis / S. Kawashima, M. Yokoyama // Arteriosclerosis, Thrombosis, and Vascular Biology. 2004. — Vol. 24, N 6. — P. 998−1005.
- Keiko, M. Statins for cardiovascular prevention according to different strategies: a cost analysis / M. Keiko, V. Rodorrdr, F. Paccaud, G. Waeber, P. Vollenweider // American J of Cardiovascular Drugs. 2011. — Vol. 3. — P.245.
- Kelley, G.A. Impact of progressive resistance training on lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials / G.A.
- Kelley, K.S. Kelley // Prev Med. 2009. — Vol. 48. — P. 9−19.
- Keys, A. Indices of relative weight and obesity / A. Keys, F. Fidanza, M. Karvone et al. // J. Chron. Dis. 1972. — Vol. 6. — P. 328−343.
- Khera, A.V. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis / A.V. Khera, M. Cuchel, M. de la Llera-Moya et al. // N Engl J Med.-2011.-Vol. 364.-P. 127−135.
- Kiechl, S. Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease / S. Kiechl, G. Schett, G. Wenning et al. // Circulation. -2004. Vol. 109. — P. 2175−2180.
- Kim, S.M. Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity / S.M. Kim, J. Lee, O.H. Ryu et al. // Clinical Endocrinology. 2005. — Vol. 63. — P. 594−598.
- Kingwell, B.A. Nitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease / B.A. Kingwell // FASEB J. 2000. — Vol. 14. — P. 1685−1696.
- Koh, K.K. Differential metabolic effects of distinct statins / K.K. Koh, I. Sakuma, M.J. Quon // Atherosclerosis. 2011. — Vol. 215, N 1. — P. 1−8.
- Kones, R. Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease—a perspective / R. Kones // Drug Des Devel Ther. 2010. — Vol. 4. — P. 383−413.
- Korhonen, P. Assessment ofcardiovascularriskin primary health care / P. Koihonen, R Vesalainen, P. Aamio et al. // Scand J Prim Health Care. 2012. — Vol. 30(2). -P. 101−6.
- Korporaal, S.J. Platelet activation by low density lipoprotein and high densitylipoprotein / S.J. Korporaal, J.W. Akkerman // Pathophysiol Haemost Thromb. -2006.-Vol. 35.-P. 270−280.
- Kozlowska-Murawska, J. Clinical usefulness of neopterin / J. Kozlowska-Murawska, A.K. Obuchowicz // Wiad Lek. 2008. — Vol. 61, N 10−12. -P. 269−272.
- Kreuter, M.W. Changing inaccurate perceptions of health risk: results from a randomized trial / M.W. Kreuter, V.J. Strecher // Health Psychol. 1995. — Vol. 14.-P. 56−63.
- Kromhout, D. N-3 Fatty acids and cardiovascular events after myocardial infarction / D. Kromhout, E.J. Giltay, J.M. Geleijnse // N Engl J Med. 2010. -Vol. 363.-P. 2015−2026.
- Kuller, L.H. The Women on the Move Through Activity and Nutrition (WOMAN) Study: Final 48-Month Results / L.H. Kuller, K.K. Pettee Gabriel, L.S. Kinzel et al. // Obesity (Silver Spring). 2011. — Epub ahead of print.
- Kurata, M. Osteopontin and carotid atherosclerosis in patients with essential hypertension / M. Kurata, T. Okura, S. Watanabe et al. // Clin Sei (Lond). 2006. -Vol. 111.-P. 319−324.
- Kuulasmaa, K. Estimatuion of contribution of changes in classic risk factors to trends in coronary event rates across the WHO MONICA Project populations / K. Kuulasmaa, R. Tunstall-Pedol, A. Dobson et al. // Lancet. 2000. — Vol. 355. — P. 675−687.
- Lampka, M Circulating endothelial cells in coronary artery disease / M. Lampka, Z. Gr^bczewska, E. Jendryczka-Mackiewicz et al. // Kardiol Pol.- 2010. -Vol. 68(10).-P. 1100−1105.
- Landmesser, U. Endothelial function: a critical determinant in atherosclerosis? / U. Landmesser, B. Hornig, H. Drexler // Circulation. 2004. — Vol. 109. — P. 27−33.
- LaRosa, J.C. Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease / J.C. LaRosa, S.M. Grundy,
- D.D. Waters et al. //N Engl J Med. 2005. — Vol. 352, N 14. — P. 1425−1435.
- Lavie, CJ. Impact of exercise training on psychological risk factors / CJ. Lavie, R.V. Milani, J.H. O’Keefe, T J. Lavie // Prog Cardiovasc Dis. 2011. — Vol. 53, N 6. — P. 464−470.
- Leaf, A. Omega-3 fatty acids and prevention of arrhythmias / A. Leaf // Curr Opin Lipidol. 2007. — Vol. 18. — P. 31 -34.
- Lee, S. Effects of interventions on oxidative stress and inflammation of cardiovascular diseases / S. Lee, Y. Park, M.Y. Zuidema et al. // World J Cardiol. 2011. — Vol. 3, N 1. — P. 18−24.
- Lefevre, P. Detection of circulating endothelial cells in thrombotic thrombocytopenic purpura / P. Lefevre // Thromb. Haemost. 1993. — Vol. 69. — P. 522.
- Leitinger, N. Oxidized phospholipids as modulators of inflammation in atherosclerosis / N. Leitinger // Curr Opin Lipidol. 2003. — Vol. 14. — P. 421−430.
- Leone, A. Interactive effect of combined exposure to active and passive smoking on cardiovascular system / A. Leone // Recent Pat Cardiovasc Drug Discov.- 2011. -Vol. 6, N 1. P. 61−69.
- Levitan, E.B. Fish consumption, marine omega-3 fatty acids, and incidence of heart failure: a population-based prospective study of middle-aged and elderly men /
- E.B. Levitan, A. Wolk // Eur Heart J. 2009. — Vol. 30, N 12. — P. 1495−1500.
- Liao, J.K. Pleiotropic effects of statins / J.K. Liao, U. Laufs // Ann Rev Pharmacol Toxicol. 2005. — Vol. 45.-P. 89−118.
- Libby, P. Current concepts of the pathogenesis of the acute coronary syndromes / P. Libby // Circulation. 2001. — Vol. 104. — P. 365−372.
- Lin, Y. Origins of circulating endothelial cells and endothelial outgrowth from blood / Y. Lin, D.J. Weisdorf, A. Solovey, R.P. Hebbel // J Clin Invest. 2000. -Vol. 105, N 1.-P. 71−77.
- Liu, H.H. Association between high sensitivity C-reactive protein levels in serum and the 5-year-accumulative-risk of diabetes / H.H. Liu, D. Zhao, W. Wang et al. // Zhonghua Liu Xing Bing Xue Za Zhi. 2011. — Vol. 32, N 1. — P. 1.-4.
- Liu, S. Intake of vegetables rich in carotenoids and risk of coronary heart disease in men: The Physicians' Health Study / S. Liu, I.-M. Lee, U. Ajani et al. // Int J of Epidemiology. -2001. Vol. 30. — P. 130−135.
- Liviakis, L. Carotid intima-media thickness for the practicing lipidologist / L. Liviakis, B. Pogue, P. Paramsothy et al. // J Clin Lipidol. 2010. — Vol. 4, N 1. — P. 24−35.
- Llevadot, J. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells / J. Llevadot, S. Murasawa, Y. Kureishi et al. // J Clin Invest.-2001.-Vol. 108.-P. 399−405.
- Lobo, R.A. Postmenopausal hormones and coronary artery disease: potential benefits and risks / R.A. Lobo // Climacteric. 2007. — N 2. — P. 21−26.
- Lowensteyn, I. Can computerized risk profiles help patients improve their coronary risk? The results of the Coronary Health Assessment Study (CHAS) /1. Lowensteyn, L. Joseph, C. Levinton et al. // Prev Med. 1998. — Vol. 27. — P. 730−737.
- Luepker, R.V. Cardiovascular Disease: Rise, Fall, and Future Prospects / R.V. Luepker // Ann Rev Public Health. 2011. — Vol. 32. — P. 1−3.
- Luscher, T.F. 1993 Mack Forster Award Lecture. Review. The endothelium as a target and mediator of cardiovascular disease / T.F. Luscher // Eur J Clin Invest. 1993. — Vol. 23, N 11. — P. 670−685.
- Luscher, T.F. Biology of the endothelium / T.F. Luscher, M. Barton // Clin. Cardiol. 1997. — Vol. 20, N 11 (Suppl. 2). — P. II-3−10.
- Lusis, A.J. Genetics of atherosclerosis / A.J. Lusis, R. Mar, P. Pajukanta // Ann Rev Genomics Hum Genet. 2004. — Vol. 5. — P. 189−218.
- Lytsy, P. Cardiovascular Risk Factor Assessments and Health Behaviours in Patients Using Statins Compared to a Non-Treated Population / P. Lytsy, G. Burell, R. Westerling // Int J Behav Med. 2011. — Epub ahead of print.
- Ma, Y. Scavenger receptor BI modulates platelet reactivity and thrombosis in dyslipidemia / Y. Ma, M.Z. Ashraf, E.A. Podrez // Blood. 2010. — Vol. 116. — P. 1932−1941.
- Maeda, K. The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis / K. Maeda, Y. Noguchi, T. Fukui // Prev Med. 2003. — Vol. 37. — P. 283−290.
- Mangge, H. Inflammation, adiponectin, obesity and cardiovascular risk / H. Mangge, G. Aimer, M. Truschnig-Wilders et al. // Curr Med Chem. 2010. -Vol. 17, N36.-P. 4511−4520.
- Mari-Sanchis, A. Olive oil consumption and incidence of diabetes mellitus, in the Spanish sun cohort / A. Mari-Sanchis, J.J. Beunza, M. Bes-Rastrollo et al. // NutrHosp.-2011.-Vol. 26, N 1. P. 137−143.
- Maron, D.J. Current perspectives on statins / D.J. Maron, S. Fazio, M.F. Linton //Circulation. -2000. Vol. 101. — P. 207−213.
- Marrugat, J. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas / J. Marrugat, R. D’Agostino, L. Sullivan // Journal of Epidemiology and Community Health. 2003. — Vol. 57. — P. 634−638.
- Maskrey, B.H. Mechanisms of resolution of inflammation: a focus on cardiovascular disease / B.H. Maskrey, I.L. Megson, P.D. Whitfield, A.G. Rossi // Arterioscler Thromb Vase Biol. 2011. — Vol. 31, N 5. — P. 1001−1006.
- McAllister, R.M. Effects of high-density lipoprotein on endothelium-dependent vasorelaxation / R.M. McAllister, D.M. Morris, C.M. Weimer, M.H. Laughlin // Appl Physiol Nutr Metab. 2010. — Vol. 35. — P. 319−327.
- McGeehin, M.A. The potential impacts of climate variability and change on temperature-related morbidity and mortality in the United States / M.A. McGeehin, M. Mirabelli // Environ Health Perspect. 2001. — Vol. 109 (suppl. 2). — P. 185−189.
- Menotti, A. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study / A. Menotti, P.E. Puddu, M. Lanti // Eur Heart J. 2000. — Vol. 21.-P. 365−370.
- Menzies, D. The case for a worldwide ban on smoking in public places / D. Menzies//Curr Opin Pulm Med. -2011. -Vol. 17, N2.-P. 116−122.
- Merry, A.H. Risk prediction of incident coronary heart disease in the
- Netherlands: re-estimation and improvement of the SCORE risk function / A.H. Merry, J.M. Boer, L.J. Schouten et al. // Eur J Cardiovasc Prev Rehabil. — 2011. — Epub ahead of print.
- Messerli, F. Framingham at 50 / F. Messerli, B.S. Mittler // Lancet. 1998. -Vol. 352, N9133.-P. 1006.
- Messner, T. A temperature rise is associated with an increase in the number of acute myocardial infarctions in the subarctic area / T. Messner, V. Lundberg // Int. J. Circumpolar Health. 2002. — № 61. — P. 201−207.
- Minoretti, P. Prognostic significance of plasma osteopontin levels in patients with chronic stable angina / P. Minoretti, C. Falcone, M. Calcagnino et al. // Eur Heart J. 2006. — Vol. 27. — P. 802−807.
- Mitsios, J.V. The antiplatelet and antithrombotic actions of statins / J.V. Mitsios, A.I. Papathanasiou, J.A. Goudevenos, A.D. Tselepis // Curr Pharm Des. 2010. — Vol. 16, N 34. — P. 3808−3814.
- Miyamoto, S. Increased serum levels and expression of S100A8/A9 complex in infiltrated neutrophils in atherosclerotic plaque of unstable angina / S. Miyamoto, M. Ueda, M. Ikemoto et al. // Heart. 2008. — Vol. 94. — P. 1002−1007.
- Mokdad, A.H. The Behavioral Risk Factors Surveillance System: Past, Present, and Future / A.H. Mokdad // Ann Rev Public Health. 2009. — Vol. 30. — P. 43−54.
- Moore, K.J. Macrophages in the pathogenesis of atherosclerosis / K.J. Moore, I. Tabas // Cell. 2011. — Vol. 145, N 3. — P. 341−355.
- Moran, C.S. Association of osteoprotegerin with human abdominal aortic aneurysm progression / C.S. Moran, M. McCann, M. Karan et al. // Circulation. -2005.-Vol. 111.-P. 3119−3125.
- Murr, C. Neopterin as a marker for immune system activation / C. Murr, B. Widner, B. Wirleitner, D. Fuchs // Curr Drug Metab. 2002. — Vol. 3. — P. 175−187.
- Mutin, M. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells / M. Mutin, I. Canavy, A. Blann et al. // Blood. 1999. — Vol. 93, N 9. — P. 2951−2958.
- Mutunga, M. Circulating Endothelial Cells in Patients with Septic Shock / M. Mutunga, B. Fulton, R. Bullock et al. // Am. J. Respir. Crit. Care Med. 2001. -Vol. 163, N 1.-P. 195−200.
- Naghavi, M. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies. Part I / M. Naghavi, P. Libby, E. Falk et al. // Circulation. 2003. — Vol. 108. — P. 1664−1672.
- Napoli, M.D. Prognostic Influence of Increased C-Reactive Protein and Fibrinogen Levels in Ischemic Stroke / M.D. Napoli, F. Papa, V. Bocola // Stroke. -2001.-Vol. 32.-P. 133.
- National Cholesterol Education Program. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel // Circulation. 2002. — Vol. 106. — P. 3143−3421.
- National Institutes of Health (NIH). Clinical Guidelines on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults: The Evidence Report. Washington: Government Printing Office, 1998.
- Navas-Nacher, E.L. Risk Factors for Coronary Heart Disease in Men 18 to 39 Years of Age / E.L. Navas-Nacher, L. Colangelo, C. Beam, P. Greenland // European Heart Journal. 2001. — Vol. 134, Is. 6. — P. 433−439.
- Nayha, S. Cold and the risk of cardiovascular diseases / S. Nayha // Int. J. Circumpolar. Health. 2002. — № 61. — P. 373−380.
- Nemati, M.H. Optimal management of familial hypercholesterolemia: treatment and management strategies / M.H. Nemati, B. Astaneh // Vase Health Risk Manag. 2010. — Vol. 6. — P. 1079−1088.
- Neopterin: Still a Forgotten Biomarker // Clinical Chemistry. 2005. — Vol. 51.-P. 1902−1903.
- Neuhauser, H.K. A comparison of Framingham and SCORE-based cardiovascular risk estimates in participants of the German National Health Interview and Examination Survey 1998 / H.K. Neuhauser, U. Ellert, B.M. Kurth
- Eur J Cardiovasc Prey Rehabil. 2005. — Vol. 12(5). — P. 442−50.
- Nicholls, S.J. Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function / S.J. Nicholls, P. Lundman, J.A. Harmer et al. // J Am Coll Cardiol. 2006. — Vol. 48. — P. 715−720.
- Nicholls, S.J. Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis / S.J. Nicholls, E.M. Tuzcu, I. Sipahi et al. // JAMA. -2007. Vol. 297, N 5. — P. 499−508.
- Nieves, D.J. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largrly attributable to intra-abdominal fat / D.J. Nieves, M. Cnop, B. Retzlaff et al. // Diabetes. 2003. — Vol. 52. — P. 172−179.
- Nijjar, P. S. Role of dietary supplements in lowering low-density lipoprotein cholesterol: a review / P. S. Nijjar, F.M. Burke, A. Bloesch, D.J. Rader // J Clin Lipidol.-2010.-Vol. 4, N4.-P. 248−258.
- Nissen, S.E. Atherosclerosis in 2010: new therapeutic insights / S.E. Nissen // Nat Rev Cardiol. 2011. — Vol. 8, N2.-P. 70−72.
- Nordestgaard, B.G. Does elevated C-reactive protein cause human atherothrombosis? Novel insights from genetics, intervention trials, and elsewhere / B.G. Nordestgaard // Curr Opin Lipidol. 2009. — Vol. 20. — P. 393−401.
- Nybo, M. The capability of plasma osteoprotegerin as a predictor of cardiovascular disease: a systematic literature review / M. Nybo, L.M. Rasmussen // Uuropean Journal of Endocrinology. 2008. — Vol. 159, Is. 5. — P. 603−608.
- Okumura, K. Folate in smokers / K. Okumura, H. Tsukamoto // Clin Chim
- Acta. 2011. — Vol. 412, N 7−8. — P. 521−526.
- Oliveira, G.H. Novel serologic markers of cardiovascular risk / G.H. Oliveira // Current Atherosclerosis Reports. 2005. — Vol. 7. — P. 148−154.
- Omland, T. Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes / T. Omland, T. Ueland, A.M. Jansson et al.//J Am Coll Cardiol. 2008.-Vol. 51.-P. 627−633.
- Omland, T. Plasma Osteoprotegerin Levels in the General Population / T. Omland, M.H. Drazner, T. Ueland et al. // Hypertension. 2007. — Vol. 49. — P. 1392.
- Opie, L.H. The red wine hypothesis: From concepts to protective signalling molecules / L.H. Opie, S. Lecour // Eur Heart J. 2007. — Vol. 28. — P. 1683−1693.
- O’Rourke, M.F. The Cardiovascular Continuum extended: aging effects on the aorta and microvasculature / M.F. O’Rourke, M.E. Safar, V. Dzau // Vase Med. -2010. Vol. 15, N 6. — P. 461−468.
- Pacher, P. Nitric oxide and peroxynitrite in health and disease / P. Pacher, J.S. Beckman, L. Liaudet // Physiol. Rev. 2007. — Vol. 87. — P. 315−424.
- Pacileo, M. The role of neopterin in cardiovascular disease / M. Pacileo, P. Cirillo, S. De Rosa et al. // Monaldi Arch Chest Dis. 2007. — Vol. 68, N 2. — P. 68−73.
- Packard, R.R. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction / R.R. Packard, P. Libby // Clin Chem. -2008. Vol. 54, N 1. — P. 24−38.
- Paredes, S. Long term cardiovascular risk models' combination a new approach / S. Paredes, T. Rocha, P. de Carvalho et al. // Conf Proc IEEE Eng Med Biol Soc. — 2009. — Vol. l.-P. 4711−4714.
- Park, Y. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance / Y. Park, W.S. Harris // J Lipid Res. 2003. — Vol. 44. — P. 455−463.
- Parks, R. Stages of atherosclerosis / R. Parks // Revolution Health. 2008. — N 11.-P. 4−6.
- Parthasarathy, S. Potential Role of Oxidized Lipids and Lipopro-teins in Antioxidant Defense / S. Parthasarathy, N. Santanam // Free Rad. Res. 2000. -Vol. 33.-P. 197−215.
- Paterson, J.M. Using disease risk estimates to guide risk factor interventions: field test of a patient workbook for self-assessing coronary risk / J.M. Paterson, H.A. Llewellyn-Thomas, C.D. Naylor // Health Expect. 2002. — Vol. 5. — P. 3−15.
- Pearson, T.A. New Tools for Coronary Risk Assessment What Are Their Advantages and Limitations? / T.A. Pearson // Circulation. 2002. — Vol. 105. — P. 886.
- Pedersen, T.R. High dose atorvastatin vs usual dose simvastatin for secondary prevention after myocardial infarction / T.R. Pedersen, O. Faergeman, J.J.P. Kastelein et al. // JAMA. 2005. — Vol. 294, N 19. — P. 2437−2445.
- Peiser, L. Scavenger receptors in innate immunity / L. Peiser, S. Mukhopadhyay, S. Gordon // Curr Opin Immunol. 2002. — Vol. 14. — P. 123−128.
- Pessana, F. Subclinical atherosclerosis modeling: Integration of coronary artery calcium score to framingham equation / F. Pessana, R. Armentano, G. Chironi et al. // Conf Proc IEEE Eng Med Biol Soc. 2009. — Vol. 1. — P. 5348−5351.
- Peters, S.A. Carotid intima-media thickness: a suitable alternative for cardiovascular risk as outcome? / S.A. Peters, D.E. Grobbee, M.L. Bots // Eur J
- Cardiovasc Prev Rehabil. 2011. -Vol. 18, N2.-P. 167−174.
- Petrovic-Oggiano, G. Physical activity in prevention and reduction of cardiovascular risk / G. Petrovic-Oggiano, V. Damjanov, M. Gurinovic, M. Glibetic // Med Pregl. 2010. — Vol. 63, N 3−4. — P. 200−207.
- Petrovski, G. Resveratrol in cardiovascular health and disease / G. Petrovski, N. Gurusamy, D.K. Das // Ann N Y Acad Sci. 2011. — Vol. 1215. — P. 22−33.
- Pfister, S.L. Vascular pharmacology of epoxyeicosatrienoic acids / S.L. Pfister, K.M. Gauthier, W.B. Campbell // Adv Pharmacol. 2010. — Vol. 60. — P. 27−59.
- Picchi A. Coronaiy microvascular dysfunction in diabetes mellitus: A review / A. Picchi, S. Capobianco, T. Qiu et al. // World J Cardiol. 2010. — Vol. 2, N 11. — P. 377−390.
- Pigolkin, Iu.I. Characteristic of mortality in the Russian Federation / Iu.I. Pigolkin, Iu.V. Sidorovich // Sud Med Ekspert. 2011. — Vol. 54, N 1. — P. 14−18.
- Pipe, A.L. Smoking cessation and the cardiovascular specialist: Canadian Cardiovascular Society position paper / A.L. Pipe, M.J. Eisenberg, A. Gupta, R.D. Reid, N.G. Suskin, J.A. Stone // Can J Cardiol. 2011. — Vol. 27(2). — P. 132−7.
- Pocket Guide to Prevention of Coronary Heart Disease / International Task Force for Prevention of Coronary Heart Disease. 2003. — 128 p.
- Pool, E. H, Dunlop GR. Cancer cells in blood stream / E.H. Pool, G.R. Dunlop //Am J Cancer. 1934.-Vol. 21. — P. 99−102.
- Quercioli, A. Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signaling / A. Quercioli, F. Montecucco, M. Bertolotto et al. // Eur J Clin Invest. 2010. — Vol. 40, N 7. — P. 645−654.
- Quilici, J. Circulating Endothelial Cell Count as a Diagnostic Marker for Non-ST-Elevation Acute Coronary Syndromes / J. Quilici, N. Banzet, P. Paule et al. // Circulation.-2004.-Vol. 110.-P. 1586−1591.
- Quirici, N. Differentiation and expansion of endothelial cells from human bone marrow CD133+ cells / N. Quirici, D. Soligo, L. Caneva et al. // Br J Haematol. -2001.-Vol. 115.-P. 186−194.
- Rafii, S. Circulating endothelial precursors: mystery, reality, and promise / S. Rafii // J Clin Invest. 2000. — Vol. 105, N 1. — P. 17−19.
- Ramahi, T.M. Cardiovascular disease in the Asia Middle East Region: Global trends and local implications / T.M. Ramahi // Asia Pac J Public Health. 2010. -Vol. 22, Suppl 3. — P. 83S-89S.
- Ramey, S.L. Relationship of cardiovascular disease to stress and vital exhaustion in an urban, midwestern police department /S.L. Ramey, Y. Perkhounkova, N.R. Downing, K.R. Culp // AAOHN J. 2011. — Vol. 59, N 5. — P. 221−227.
- Ray, K.K. A Novel Marker of Monocyte Activation in Patients With Acute
- Coronary Syndrome / K.K. Ray, D.A. Morrow, M.S. Sabatine et al. // Circulation. -2007.-Vol. 115.-P. 3071−3078.
- Ray, K.K. Biomarkers, C-reactive proteins and statins in acute coronary syndromes / K.K. Ray // Fundam Clin Pharmacol. 2007. — Vol. 21, Suppl 2. — P. 31−33.
- Ray, K.K. Long-Term Prognostic Value of Neopterin: A Novel Marker of Monocyte Activation in Patients With Acute Coronary Syndrome / K.K. Ray, D.A. Morrow, M.S. Sabatine et al. // Circulation. 2007. — Vol. 115. — P. 3071−3078.
- Razani, B. Caveolae: From Cell Biology to Animal Physiology / B. Razani, S.E. Woodman, M.P. Lisanti // Pharmacol. Rev. 2002. — Vol. 54, N 3. — P. 431−467.
- Reriani, M.K. Endothelial function as a functional expression o cardiovascular risk factors /M.K. Reriani, L.O. Lerman, A. Lerman//Biomark Med. -2010. Vol. 4(3). -P. 351−360.
- Rennenberg, RJ. Arterial calcifications / RJ. Rennenberg, LJ. Schurgers, A.A. Kroon, C.D. Stehouwer // J Cell Mol Med. 2010. — Vol. 14, N 9. — P. 2203−2210.
- Retterstol, L. A daily glass of red wine: Does it affect markers of inflammation? / L. Retterstol, K.E. Berge, O. Braaten et al. // Alcohol Alcohol. -2005. Vol. 40, N 2. — P. 102−105.
- Ribeiro, F. Endothelial function and atherosclerosis: circulatory markers with clinical usefulness / F. Ribeiro, A.J. Alves, M. Teixeira et al. // Rev Port Cardiol. -2009.-Vol. 28, N 10.-P. 1121−1151.
- Ricciotti, E. Prostaglandins and inflammation / E. Ricciotti, G.A. Fitzgerald // Arterioscler Thromb Vase Biol. 2011. — Vol. 31, N 5. — P. 986−1000.
- Ridker, P.M. Inflammation, C-reactive protein, and atherothrombosis / P.M. Ridker, J.D. Silvertown // J Periodontal. 2008. — Vol. 79, N8, Suppl.-P. 1544−1551.
- Rodondi, N. Framingham risk score and alternatives for prediction of coronary heart disease in older adults /N. Rodondi, I. Locatelli, D. Aujesky et al. // / PLoS One. 2012. -Vol. 7(3). — P. e34287.
- Rogers, G.M. Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells / G.M. Rogers, R.N. Taylor, J.M. Roberts // Am J Obstetr Gynecol. 1988. — Vol. 159, N 4. — P. 908−914.
- Rohrer, L. High-density lipoprotein transport through aortic endothelial cellsinvolves scavenger receptor BI and ATP-binding cassette transporter G1 / L. Rohrer, P.M. Ohnsorg, M. Lehner et al. // Circ Res. 2009. — Vol. 104. — P. 1142−1150.
- Romano, A.D. Oxidative stress and aging / A.D. Romano, G. Serviddio, A. de Matthaeis et al. // J Nephrol. 2010. — Vol. 23, Suppl 15. — P. S29-S36.
- Rosenson, R.S. HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events /R.S. Rosenson, H.B. Jr. Brewer, M.J. Chapman et al. // Clin Chem. 2011. — Vol. 57. — P. 392−410.
- Ross, R. Atherosclerosis: an inflammatory disease / R. Ross // N Engl J Med. -1999.-Vol. 340.-P. 115−126.
- Ross, R. The pathogenesis of atherosclerosis: A perspective for the 1990s / R. Ross //Nature. 1993. -Vol. 362, N 6423. — P. 801−809.
- Rubanyi, G.M. The role of endothelium in cardiovascular homeostasis and diseases / G.M. Rubanyi // J Cardiovasc Pharmacol. 1993. — Vol. 22 (Suppl 4.). — P. SI.
- Rubbo, H. Interactions of nitric oxide and peroxynitrite with low-density lipoprotein / H. Rubbo, A. Trostchansky, H. Botti et al. // Biol. Chem. 2002. — Vol. 383. — P. 547−552.
- Rye, K.A. The metabolism and anti-atherogenic properties of HDL / K.A. Rye, C.A. Bursill, G. Lambert et al. // J Lipid Res. 2009. — Vol. 50, Suppl. — P. S195-S200.
- Salazar, M.R. Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk / M.R. Salazar, H.A. Carbajal, W.G. Espeche et al. // Diab Vase Dis Res. 2011. — Vol. 8, N 2. — p. 109−116.
- Saleem, T.S. Red wine: A drink to your heart / T.S. Saleem, S.D. Basha // J Cardiovasc Dis Res. 2010. — Vol. 1, N 4. — P. 171−176.
- Saleptsis, V.G. Depression and atherosclerosis / V.G. Saleptsis, N. Labropoulos, A. Halaris et al. // Int Angiol. 2011. — Vol. 30, N 2. — P. 97−104.
- Samman, S. Flavonoids and coronary heart disease: Dietary perspectives, in Flavonoids in Health and Disease / S. Samman, P.M.L. Wall, N.C. Cook- eds. C.A. Rice-Evans, L. Packer. New York: Marcel Dekker, 1998. — P. 469−481.
- Sampietro, T. Low high-density lipoprotein predicts death in patients with mild left ventricular dysfunction regardless of coronary atherosclerosis / T. Sampietro, F. Bigazzi, M.Puntonietal.//J Cardiovasc Med.-2009.-Vol. 10, N 12.-P. 898−905.
- Sapian-Raczkowska, B. Paraoxonase—important enzyme of the lipid metabolism and potential ally in the antiatherosclerotic treatment / B. Sapian-Raczkowska, M. Rabczynski, R. Adamiec // Pol Merkur Lekarski. 2010. — Vol. 29, N 173. — P. 325−327.
- Sasaki, J. Exercise therapy for prevention of atherosclerosis / J. Sasaki // Nippon Rinsho.-2011.-Vol. 69, N l.-P. 119−124.
- Sasaki, T. High Serum Level of Neopterin Is a Risk Factor of Patients with Heart Failure / T. Sasaki- Y. Takeishi- T. Shishido et al. // Circulation. 2008. — Vol. 118. — P. 619−620.
- Sassen, B. Predictors of healthcare professionals' intention and behaviour to encourage physical activity in patients with cardiovascular risk factors / B. Sassen, G. Kok, L. Vanhees // BMC Public Health. 2011. — Vol. 19, N 11. — P. 246.
- Sata, M. Oxidized LDL activates fas-mediated endothelial cell apoptosis / M. Sata, K. Walsh // J Clin Invest. 1998. — Vol. 102. — P. 1682−1689.
- Sbarbati, R. Immunologic detection of endothelial cells in human whole blood / R. Sbarbati, M. de Boer, M. Marzilli et al. // Blood. 1991. — Vol. 77. — P. 764−769.
- Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) // Lancet. 1994. — Vol. 344, N 8934. — P. 1383−1389.
- Schneider, M.P. Contrasting Actions of Endothelin ETA and ETB Receptors in
- Cardiovascular Disease / M.P. Schneider, E.I. Boesen, D.M. Pollock // Ann Rev Pharmacol Toxicol. 2007. — Vol. 47.-P. 731−759.
- Schobersberger, W. Induction of inducible nitric oxide synthase expression by neopterin in vascular smooth muscle cells / W. Schobersberger, G. Hoffmann, J. Grote et al. // FEBS Lett. 1995. — Vol. 377. — P. 461−464.
- Schoppet, M. Increased osteoprotegerin serum levels in men with coronary artery disease / M. Schoppet, A.M. Sattler, J.R. Schaefer et al. // J Clin Endocrinol Metab. 2003. — Vol. 88. — P. 1024−1028.
- Schulze, P.C. Oxidative stress and atherosclerosis / P.C. Schulze, R.T. Lee // Current Atherosclerosis Reports. 2005. — Vol. 7. — P. 242−248.
- Schumacher, M. Increased neopterin in patients with chronic and acute coronary syndromes / M. Schumacher, G. Hal wachs, F. Tatzber et al. // J Am Coll Cardiol. 1997. — Vol. 30. — P. 703−707.
- Schwandt, P. Nutrition and Cardiovascular Risk Factors in Four Age Groups of Female Individuals: The PEP Family Heart Study / P. Schwandt, G.M. Haas, T. Bertsch//Int JPrevMed.-2010.-Vol. 1. N2.-P. 103−109.
- Segal, M.S. Circulating endothelial cells: tea leaves for renal disease / M.S. Segal, A. Bihorac, M. Ko? // Am J Physiol Renal Physiol. 2002. — Vol. 283. — P. F11-F19.
- Shafiq, N. Dietary treatment for familial hypercholesterolaemia / N. Shafiq, M. Singh, S. Kaur et al. // Cochrane Database Syst Rev. 2010. -N 1. — CD001918.
- Shah, P.K. Mechanisms of plaque vulnerability and rupture / P.K. Shah // J Am Coll Cardiol. -2003. Vol. 41. — P. 15S-22S.
- Shaltoni, H.M. Statins and stroke prevention / H.M. Shaltoni, F.M. Yatsu, D.C. Hess // Current Atherosclerosis Reports. 2005. — Vol. 7. — P. 313−318.
- Shephard, G. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia West of Scotland Coronary Prevention Study Group (WOSCOPS) / G. Shephard, S.M. Cobbe, J. Fordet al. //N. Engl. J. Med. -1995. Vol. 333. -P. 1301−1307.
- Sheridan, S. Framingham-based Tools to Calculate the Global Risk of Coronary Heart Disease: A Systematic Review of Tools for Clinicians / S. Sheridan, M. Pignone, C. Mulrow// Journal ofGeneral Internal Medicine.-2003.-Vol. 18, N 12.-P. 1039−1052.
- Sherwood, N. E. The behavioral determinants of exercise: implications for physical activity interventions / N.E. Sherwood, R.W. Jeffery // Annu Rev Nutr. -2000. Vol. 20. — P. 21−44.
- Shi, G. Platelets as initiators and mediators of inflammation at the vessel wall / G. Shi, C.N. Morrell // Thromb Res. 2011. — Vol. 127, N 5. — P. 387−390.
- Shioi, A. Molecular mechanisms of vascular calcification / A. Shioi // Clin Calcium. 2010. — Vol. 20, N 11. — P. 1611−1619.
- Sibal, L. Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes / L. Sibal, S.C. Agarwal, P.D. Home // Diabetes Metab Syndr Obes. 2011. — Vol. 4. — P. 23−34.
- Siervo, M. Post-challenge hyperglycaemia, nitric oxide production and endothelial dysfunction: the putative role of asymmetric dimethylarginine (ADMA) / M. Siervo, M. Corander, S. Stranges, L. Bluck // Nutr Metab
- Cardiovasc Dis. 2011. — Vol. 21, N 1. — P. 1 -10.
- Simon, A. Differential effects of nifedipin and co-amilozid on the progression of early carotid wall change / A. Simon // Circulation. 2001. — Vol. 103. — P. 2949−2954.
- Simone, H. Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-" associated with induction of angiopoietin-2 /
- H. M. Simone, A. Van Campenhout, C. Rush, J. Golledg // Cardiovascular Research. 2007. — Vol. 76(3). — P. 494−505.
- Singh, U. Vitamin E, oxidative stress, and inflammation / U. Singh, S. Devaraj,
- Jialal // Ann Rev Nutr. 2005. — Vol. 25. — P. 151−174.
- Sivapalaratnam, S. Genome-wide association studies in atherosclerosis / S. Sivapalaratnam, M.M. Motazacker, S. Maiwald et al. // Curr Atheroscler Rep. -2011.-Vol. 13, N3.-P. 225−232.
- Sniderman, A. Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol? / A. Sniderman, M. McQueen, J. Contois et al. // J Clin Lipidol. 2010. — Vol. 4, N 3. — P. 152−155.
- Society of Atherosclerosis Imaging and Prevention Developed in collaboration with the International Atherosclerosis Society. Appropriate use criteria for carotid intima media thickness testing // Atherosclerosis. 2011. — Vol. 214, N 1. — P. 43−46.
- Solovey, A. Circulating activated endothelial cells in sickle cell anemia / A. Solovey, Y. Lin, P. Browne et al. //N. Engl. J. Med. 1997. — Vol. 337. — P. 1584−1590.
- Soska, V. Residual risk of cardiovascular complications and its reduction with a combination oflipid lowering agents / V. Soska//VnitrLek.-2011.-Vol. 57, N3.-P. 313−316.
- Sowemimo-Coker, S.O. Increased circulating endothelial cells in sickle cell crisis / S.O. Sowemimo-Coker, H.J. Meiselman, R.B.Jr. Francis // Am. J. Hematol.- 1989.- Vol. 31.-P. 263−265.
- Sowers, J.R. Hypertension, angiotensin II, and oxidative stress / J.R. Sowers //
- N Engl J Med. 2002. — Vol. 346.-P. 1999−2001.
- Spagnoli, L.G. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke / L.G. Spagnoli, A. Mauriello, G. Sangiorgi et al. // JAMA. -2004.-Vol. 292.-P. 1845−1852.
- Speidl, W.S. Complement in atherosclerosis: friend or foe? / W.S. Speidl, S.P. Kastl, K. Huber, J. Wojta // J Thromb Haemost. 2011. — Vol. 9, N 3. — P. 428−440.
- Sposito, A.C. Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefit / A.C. Sposito, M.J. Chapman // Arterioscler Thromb Vase Biol. 2002. — Vol. 22. — P. 1524−1534.
- Steinberg, D. Oxidative modification of LDL and atherogenesis / D. Steinberg //Circulation. 1997.-Vol. 95.-P. 1062−1071.
- Stephen, S.L. Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease / S.L. Stephen, K. Freestone, S. Dunn et al. // Int J Hypertens. 2010. — Vol. 2010. — P. 646 929.
- Stapien, E. Increased levels of bone remodeling biomarkers (osteoprotegerin and osteopontin) in hypertensive individuals / E. St^pien, E. Wypasek, K. Stopyra et al. // Clin Biochem. 2011. — Epub ahead of print.
- Steptoe, A. Behavioural counselling in general practice for the promotion of healthy behaviour among adults at increased risk of coronary heart disease: randomised trial / A. Steptoe, S. Doherty, E. Rink et al. // BMJ. 1999. — Vol. 319. — P. 943−948.
- Stocker, R. Role of oxidative modifications in atherosclerosis / R. Stocker, J.F. Keaney // Physiol. Rev. 2004. — Vol. 84. — P. 1381−1478.
- Stoll, G. Inflammation and atherosclerosis: novel insights into plaque formation anddestabilization / G. Stoll, M. Bendszus // Stroke. 2006. — Vol. 37, N 7. — P. 1923−1932.
- Syvanen, K. Endothelial function in a cardiovascular risk population with borderline ankle-brachial index / K. Syvanen, P. Korhonen, A. Partanen // Vascular Health and Risk Management. 2011. — Vol. 7. — P. 97−101.
- Szulc, P. Osteoprotegerin serum in men: correlation with age, estrogen, and testosterone status / P. Szulc, L.C. Hofbauer, A.E. Heufelder et al. // Journal of Clinical Endocrinology and Metabolism. 2001. — Vol. 86. — P. 3162−3165.
- Tabet, F. High density lipoproteins, inflammation and oxidative stress / F. Tabet, K.A. Rye // Clin. sci. 2009. — Vol. 116, N 2. — P. 87−98.
- Tada, N. Dietary therapy for prevention and treatment of atherosclerosis from the perspective of anti-inflammation / N. Tada // Nippon Rinsho. 2011. — Vol. 69, N1. — P. 110−118.
- Takahashi, M. Inflammatory cytokines in the pathogenesis of atherosclerosis / M. Takahashi // Nippon Rinsho. 2011. — Vol. 69, N 1. — P. 30−33.
- Takemoto, M. Prevention, treatment and management of inflammation in atherosclerosis / M. Takemoto, K. Yokote // Nippon Rinsho. 2011. — Vol. 69, N1. — P. 18−24.
- Takizawa, H. Increased expression of inflammatory mediators in small-airway epithelium from tobacco smokers / H. Takizawa, M. Tanaka, K. Takami et al. // Am. J. Physiol. Lung Cell. Mol. Physiol. 2000. — Vol. 278. — P. 906−913.
- Tarry-Adkins, J.L. Mechanisms of early life programming: current knowledge and future directions / J.L. Tarry-Adkins, S.E. Ozanne // Am J Clin Nutr. 2011. — Epub ahead of print.
- Tchemof, A. Weight loss reduces C-reactive protein levels in obese postmenopausal women / A. Tchemof, A. Nolan, C.K. Sites et al. // Circulation. 2002. — Vol. 10. — P. 564−569.
- Teerlink, J.R. Endothelins: Pathophysiology and treatment implications in chronic heart failure / J.R. Teerlink // Current Heart Failure Reports. 2005. — Vol. 2. — P. 191−197.
- Thompson, G.R. Management of dyslipidemia / G.R. Thompson // Heart. -2004.-Vol. 90.-P. 949−955.
- Thorin-Trescases, N. Age-dependent oxidative stress: toward an irreversible failure in endothelial maintenance / N. Thorin-Trescases, G. Voghel, N. Farhat et al. // Med Sci (Paris). 2010. — Vol. 26, N 10. — P. 875−880.
- Thyfault, J.P. Lack of regular physical exercise or too much inactivity / J.P. Thyfault, F.W. Booth // Curr Opin Clin Nutr Metab Care. 2011. — Epub ahead of print.
- Tousoulis, D. Endothelial dysfunction: potential clinical implications / D. Tousoulis, M. Koutsogiannis, N. Papageorgiou et al. // Minerva Med. 2010. — Vol. 101, N4.-P. 271−284.
- Tousoulis, D. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease / D. Tousoulis, G. Siasos, K. Maniatis et al. // Int J Cardiol. 2012. Epub ahead of print.
- Trochu, J-N. Role of Endothelium-Derived Nitric Oxide in the Regulation of Cardiac Oxygen Metabolism / J-N. Trochu, J-B. Bouhour, G. Kaley, T.H. Hintze // Circ Res. 2000. — Vol. 87. — P. 1108.
- Tsuruda, T. Macrophage: pathogenesis in the progression of atherosclerosis / T. Tsuruda, K. Hatakeyama, K. Kitamura // Nippon Rinsho. 2011. -'Vol. 69, N1. — P. 45−49.
- Tzotzas, T. Obesity, weight loss and conditional cardiovascular risk factors / T. Tzotzas, P. Evangelou, D.N. Kiortsis // Obes Rev. 2011. — Vol. 12, N 5. — P. e282-e289.
- Ueda, M. Clinical relevance of coronary artery calcification, as a risk factor for plaque rupture: viewpoint from pathology / M. Ueda // Clin Calcium. 2010. -Vol. 20, N 11.-P. 1656−1662.
- Ueland, T. Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure / T. Ueland, A. Yndestad, E. Oie et al. // Circulation.-2005.-Vol. 111.-P. 2461−2468.
- Ueland, T. Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction / T. Ueland, R. Jemtland, K. Godang et al. // J Am Coll Cardiol. 2004. — Vol. 44. — P. 1970−1976.
- Uemura, H. Circulating osteoprotegerin is associated with age and systolic blood pressure, but not with lipid profile or fasting glucose, in postmenopausal women / H. Uemura, T. Yasui, Y. Miyatani et al. // Menopause. 2008. — Vol. 15. — P. 180−184.
- Ugur-Altun, B. The relationship between insulin resistance assessed by HOMA-IR and serum osteoprotegerin levels in obesity / B. Ugur-Altun, A. Altun, M. Gerenli, A. Tugrul // Diabetes Research and Clinical Practice. 2005. — Vol. 68. — P. 217−222.
- Unal, B. Life-Years Gained From Modern Cardiological Treatments and Population Risk Factor Changes in England and Wales, 1981−2000 / B. Unal, J.A. Critchley, D. Fidan, S. Capewell // Am J Public Health. 2005. — Vol. 95, N 1. — P. 103−108.
- Valensi, P. Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: A review of the literature / P. Valensi, L. Lorgis, Y. Cottin // Arch Cardiovasc Dis. 2011. — Vol. 104, N 3. — P. 178−188.
- Vapaatalo, H. Clinically important factors influencing endothelial function / H. Vapaatalo, E. Mervaala // Med Sci Monit. 2001. — Vol. 7. — P. 1075−1085.
- Vasa, M. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease / M. Vasa, S. Fichtlscherer, A. Aicher et al. // Circ Res. 2001. — Vol. 89. — P. E1-E7.
- Vasilevko, V. Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy / V. Vasilevko, G.F. Passos, D. Quiring et al. // Ann N Y Acad Sci. 2010. — Vol. 1207. — P. 58−70.
- Venuraju, S.M. Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity / S.M. Venuraju, A. Yerramasu, R. Corder, A. Lahiri // J Am Coll Cardiol. 2010. — Vol. 55, N 19. — P. 2049−2061.
- Vergeer, M. The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis? / M. Vergeer, A.G. Holleboom, J.J. Kastelein, J.A. Kuivenhoven // J Lipid Res. 2010. — Vol. 51. — P. 2058−2073.
- Villablanca, A.C. Atherosclerosis and sex hormones: current concepts / A.C. Villablanca, M. Jayachandran, C. Banka// Clin Sci (Lond). -2010. Vol. 119, N12. -P. 493−513.
- Voogdt-Pruis, H.R. Experiences of doctors and nurses implementing nurse-delivered cardiovascular prevention in primary care: a qualitative study / H.R. Voogdt-Pruis, G.H. Beusmans, A.P. Gorgels, J.W. van Ree // J Adv Nurs. 2011. — Epub ahead of print.
- Wald, N.J. Screening for Future Cardiovascular Disease Using Age Alone Compared with Multiple Risk Factors and Age / N.J. Wald, M. Simmonds, J.K. Morris // PLoS ONE. 2011. — Vol. 6(5). — P. el 8742.
- Wallis, E.J. Coronary and cardiovascular risk estimation for primary prevention:
- Validation of a new Sheffield table in the 1995 Scottish health survey population / EJ. Wallis, L.E. Ramsay, I.U. Haq et al. // BMJ. 2000. — Vol. 320. — P. 671−676.
- Walter, R.B. HMG-CoA reductase inhibitors are associated with decreased serum neopterin levels in stable coronary artery disease / R.B. Walter, D. Fuchs, G. Weiss et al. // Clin Chem Lab Med. 2003. — Vol. 41. — P. 1314−1319.
- Wang, J. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia / J. Wang, M.B. Lanktree, H. Cao et al. // Nat Genet. 2010. — Vol. 42. — P. 684−687.
- Wang, X. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo / X. Wang, H.L. Collins, M. Ranalletta et al. // J Clin Invest. 2007. — Vol. 117. — P. 2216−2224.
- Wang, Y. Adaptations to exercise training within skeletal muscle in adults with type 2 diabetes or impaired glucose tolerance: a systematic review / Y. Wang, D. Simar, M.A. Fiatarone Singh // Diabetes Metab Res Rev. 2009. — Vol. 25. — P. 13−40.
- Wautier, J.L. Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications / J.L. Wautier, R.C. Panton, M.P. Wautier et al. // N Engl J Med. 1981. — Vol. 305, N 5. — P. 237−242.
- Weimer, R. Post-transplant sCD30 and neopterin as predictors of chronic allograft nephropathy: impact of different immunosuppressive regimens / R. Weimer, C. Susal, S. Yildiz et al. // Am J Transplant. 2006. — Vol. 6. — P. 1865−1874.
- Weiss, G. Increased concentrations of neopterin in carotid atherosclerosis / G. Weiss, J. Willeit, S. Kiechl et al. // Atherosclerosis. 1994. — Vol. 106. — P. 263−271.
- Werner-Felmayer, G. Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP / G. Werner-Felmayer, E.R. Werner, D. Fuchs et al. // J Biol Chem. 1993. — Vol. 268. — P. 1842−1846.
- Wigren, M. Atherosclerosis: cell biology and lipoproteins / M. Wigren, H. Bjorkbacka // Curr Opin Lipidol. 2010. — Vol. 21, N 1. — P. 97−98.
- Wijendran, V. Dietary N-6 and N-3 fatty acid balance andcardiovascular health / V. Wijendran, K.C. Hayes // Ann Rev Nutr. 2004. — Vol. 24. — P. 597−615.
- Wilkins, J.T. Lifetime risk and years lived free of total cardiovascular disease / J.T. Wilkins, H. Ning, J. Berry et al. // JAMA. 2012/ - Vol. 7, N 308(17). — P. 1795−801.
- Wilson, P.W. Prediction of coronary heart disease using risk factor categories / P.W. Wilson, R.B. D’Agostino, D. Levy et al. // Circulation. 1998. — Vol. 97. -P. 1837−1847.
- Wilson, S. Comparison of methods to identify individuals at increased risk of coronary disease from the general population / S. Wilson, A. Johnston, J. Robson et al. // BMJ. 2003. — Vol. 326. — P. 1436−1441.
- Wirleitner, B. Neopterin derivatives to activate NF-kappa B / B. Wirleitner, G. BaierBitterlich, G. Hoffinann et al. //Free Radic Biol Med. -1997. Vol. 23, N1. -P. 177−179.
- Wood, F.O. Sorting through new biomarkers / F.O. Wood, J.A. de Lemos // Curr Cardiol Rep.-2008.-Vol. 10, N4.-P. 319−326.
- Woollard, K.J. Monocytes in atherosclerosis: subsets and functions / K.J. Woollard, F. Geissmann // Nat Rev Cardiol. 2010. — Vol. 7, N 2. — P. 77−86.
- Woywodt, A. Circulating endothelial cells: life, death, detachment and repair of the endothelial cell layer / A. Woywodt, F.H. Bahlmann, K. de Groot et al. //
- Nephrol Dial Transplant. 2002. — Vol. 17. — P. 1728−1730.
- Xiang, G. Plasma Osteoprotegerin and Endothelium-Dependent Arterial Dilation in Type 2 Diabetes / G. Xiang, L. Xu, L. Zhao et al. // Diabetes. 2006. -Vol. 55.-P. 2126−2131.
- Yamaguchi, A. Vascular calcification: mutual interaction between bone and blood vessel // A. Yamaguchi, T. Akashi // Clin Calcium. 2010. — Vol. 20, N11. — P. 1669−1676.
- Yang, C. Prostaglandin E receptors as inflammatory therapeutic targets for atherosclerosis / C. Yang, X. Liu, Q. Cao et al. // Life Sci. 2011. — Vol. 88, N 5−6. -P. 201−205.
- Yang, Z. HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins / Z. Yang, T. Kozai,
- B. Van der Loo et al. // J. Am. Coll. Cardiol. 2000. — Vol. 36. — P. 1691−1697.
- Yoshida, M. Vascular calcification and serum markers / M. Yoshida, H. Tomiyama, A. Yamashina // Clin Calcium. 2010. — Vol. 20, N 11. — P. 1694−1699.
- Yusuf, S. Effect of potentially modifirable risk factors associated with myocardial infarction in 52 countries (the INTERHEART Study): case-control study / S. Yusuf, S. Hawken, S. Ounpuu et al. // Lancet. 2004. — Vol 364. — P. 937−952.
- Zanobetti, A. Gene-air pollution interaction and cardiovascular disease: a review / A. Zanobetti, A. Baccarelli, J. Schwartz // Prog Cardiovasc Dis. 2011. -Vol. 53, N5.-P. 344−352.
- Zheng, C. Dietary monounsaturated fat activates metabolic pathways for triglyceride-rich lipoproteins that involve apolipoproteins E and C-III / C. Zheng,
- C. Khoo, J. Furtado et al. // Am J Clin Nutr. 2008. — Vol. 88. — P. 272−281.
- Zouridakis, E. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris / E. Zouridakis, P. Avanzas, R. Arroyo-Espliguero et al. // Circulation. 2004. — Vol. 110. — P. 1747−1753.